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PIEZOELECTRIC SCAFFOLDS FOR OSTEOCHONDRAL DEFECT REPAIR 
by 
Sita Mahalakshmi Damaraju 
Osteoarthritis is one of the most prevalent causes of disability affecting nearly 27 
million Americans. Osteoarthritis is caused when extensive damage occurs to the 
articular cartilage later spreading to the underlying subchondral bone, resulting in 
osteochondral defects. The current clinical therapies aim at regenerating the hyaline 
cartilage, but instead fibrocartilage forms at the osteochondral defect site, which is 
inferior in structure and function and fails to integrate with the surrounding tissue. A 
biomimetic scaffold, which can provide cues similar to the native extracellular matrix, 
may facilitate osteochondral defect repair. Articular cartilage and bone extracellular 
matrix have been shown to produce electrical potentials when subjected to mechanical 
loading. The electrical behavior of cartilage and bone may provide signals for tissue 
repair and remodeling during injury and homeostasis. Therefore, a piezoelectric 
scaffold, which is able to generate electrical charge in response to deformation, is 
investigated in this study for its potential to support hyaline cartilage and bone tissue 
formation in combination with human mesenchymal stem cells (MSCs). The scaffold is 
composed of the synthetic polymer, poly(vinylidene fluoride-co-trifluoroethylene) 
(PVDF-TrFE), a biocompatible, piezoelectric polymer. It is hypothesized that 
piezoelectric scaffolds will promote chondrogenic (cartilage) and osteogenic (bone) 
differentiation of MSCs. PVDF-TrFE is electrospun to form a fibrous, three-dimensional 
scaffold (as-spun). PVDF-TrFE scaffolds are further annealed to enhance piezoelectric 
properties (annealed). The chondrogenic and osteogenic differentiation of MSCs is 
 
 
evaluated on both as-spun and annealed PVDF-TrFE scaffolds in a perfused 
compression bioreactor system to simulate physiological loading. Electrospun 
polycaprolactone (PCL) is used as a non-piezoelectric control. Under physiological 
loading conditions, annealed PVDF-TrFE scaffolds have a higher voltage output 
compared to as-spun PVDF-TrFE scaffold. In bioreactor cultures, MSC chondrogenic 
differentiation is promoted on as-spun PVDF-TrFE and osteogenic differentiation is 
enhanced on annealed PVDF-TrFE scaffolds when compared to PCL control. These 
results suggest that MSCs differentiation behavior can be impacted by the differences in 
voltage output from the as-spun and annealed PVDF-TrFE, indicating a role for 
electromechanical stimulus on MSC differentiation. Therefore, piezoelectric scaffolds 
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1.1 Stages of progressive joint osteoarthritis………………………………... 2 
 
1.2 Osteochondral tissue showing A) different zones of cartilage B) features 










2.2 Force transducers testing setup (a) force transducer (scale bar = 63.5 
mm), (b) cross-section of force transducer and  (c) schematic of the 





2.3 SEM images of as-spun PVDF-TrFE (a) & (d), annealed PVDF-TrFE 
(b) & (d) and PCL (c) & (f) at 500X and 2000X. Scale bar at 500X = 





2.4 DSC spectrums for (i) as-spun PVDF-TrFE and (ii) annealed PVDF-














2.7 Piezo force microscopy (PFM) voltage butterfly loops for as-spun 
PVDF-TrFE (a, d), annealed PVDF-TrFE (b, e) and PCL fibers (c) in 





2.8 Confocal images of cells in CCM+ medium where cells were placed on 
as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL scaffolds for up to 
28 days. Cultures stained for F-actin (red), nucleus (blue), and collagen 






2.9 Cell proliferation shown as fold change since day 1 in CCM+ medium 
where cells were placed on as-spun PVDF-TrFE, annealed PVDF-TrFE 
and PCL scaffolds for up to 28 days. a p<0.05 significant difference 
between days 1 and 14 and b p <0.05 significant difference between 















2.10 Glycosaminoglycan production (a) Total GAG per scaffold and (b) total 
GAGs normalized to cell number in CCM+ medium where cells were 
placed on as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL 
scaffolds for up to 28 days. *p<0.05 significant difference between 
groups, a p<0.05 significant difference between days 1 and 14 and b 









2.11 Gene expression for cells in CCM+ medium where cells were placed on 
as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL scaffolds for up to 
28 days. (a) Focal adhesion kinase (FAK) (b) SOX9 (c) aggrecan (d) 
collagen type II (e) chondroadherin where *p<0.05 significant 
difference between groups, a p<0.05 significant difference between days 
1 and 14, b p<0.05 significant difference between days 14 and 28 and c 










2.12 Confocal images of cells in OS medium where cells were placed on as-
spun PVDF-TrFE, annealed PVDF-TrFE and PCL scaffolds for up to 28 
days. Cultures stained for F-actin (red), nucleus (blue), collagen type I 






2.13 Cell number for cells in OS medium for up to 28 days. a p<0.05 
significant difference between days 7 and 14, b p<0.05 significant 





2.14 Alkaline phosphatase activity normalized to cell number on as-spun and 
annealed PVDF-TrFE and PCL scaffolds in OS medium for up to 28 
days. *p<0.05 significant difference between groups, a p<0.05 
significant difference between days 7 and 14, b p<0.05 significant 
difference between days 14 and 21 and c p<0.05 significant difference 








2.15 Calcium or mineralization of the extracellular matrix for cells on as-
spun and annealed PVDF-TrFE and PCL scaffolds in OS medium for up 
to 28 days. *p<0.05 significant difference between groups, #p<0.05 






3.1 Confocal images of cells attached to scaffolds on day 0. Cultures stained 




3.2 The number of cells attached to as-spun PVDF-TrFE, annealed PVDF-










3.3 Cartilage tissue constructs at day 28 which underwent dynamic 




3.4 Biochemical analysis for MSCs chondrogenesis on PCL, as-spun 
PVDF-TrFE and annealed PVDF-TrFE scaffolds. Plots show cell 
number (a), total GAGs production (b), collagen type II production (c), 
collagen type I production (d) when normalized to perfusion only 
groups and collagen types II/I ratio (e) at days 14 and 28. At specific 
time point, significant difference between groups is noted by ^ p<0.05. 
Within a specific group, significant difference between time points is 
noted by # p<0.05. When all three groups are significantly different is 












3.5 Chondrogenic gene expression for SOX9 (a), aggrecan (b), collagen 
type II (c), collagen type IX (d), chondroadherin (e), collagen type I (f) 
and collagen type X (h) for MSCs cultured on as-spun PVDF-TrFE, 
annealed PVDF-TrFE and PCL scaffolds at days 14 and 28. At specific 
time point, significant difference between groups is noted by ^ p<0.05. 
Within a specific group, significant difference between time points is 
noted by # p<0.05. When all three groups are significantly different is 










3.6 As-spun PVDF-TrFE scaffolds confocal images showing tissue cross-
section (scale bar = 500 µm) and distribution of collagen type II, SOX9 
and collagen type I proteins within that cross section cultured in 
chondrogenic media, which underwent dynamic compression at days 14 
and 28. Scaffolds without cells (control) and scaffolds with cultures 
stained for SOX9 (green), collagen type I (green), collagen type II 









3.7 Annealed PVDF-TrFE scaffolds confocal images showing tissue cross-
section (scale bar = 500 µm) and distribution of collagen type II, SOX9 
and collagen type I proteins within that cross section cultured in 
chondrogenic media, which underwent dynamic compression at days 14 
and 28. Scaffolds without cells (control) and scaffolds with cultures 
stained for SOX9 (green), collagen type I (green), collagen type II 
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3.8 PCL scaffolds confocal images showing tissue cross-section (scale bar = 
500 µm) and distribution of collagen type II, SOX9 and collagen type I 
proteins within that cross section cultured in chondrogenic media, which 
underwent dynamic compression at days 14 and 28. Scaffolds without 
cells (control) and scaffolds with cultures stained for SOX-9 (green), 
collagen type I (green), collagen type II (green), F-actin (red) and 









3.9 Tissue constructs in osteogenic media, which underwent dynamic 




3.10 Biochemical analysis for MSCs osteogenesis on PCL, as-spun PVDF-
TrFE and annealed PVDF-TrFE scaffolds. Plots show cell number (a), 
total alkaline phosphatase activity (b), mineralization (c) and osteocalcin 
(d) where dynamic group is normalized to perfusion only group at days 
14 and 28. At specific time point, significant difference between groups 
is noted by ^ p<0.05. Within a specific group, significant difference 
between time points is noted by # p<0.05. When all three groups are 










3.11 Gene expression analysis for MSCs osteogenesis on PCL, as-spun 
PVDF-TrFE and annealed PVDF-TrFE scaffolds. Plots show alkaline 
phosphatase (a), RUNX2 (b), collagen type I (c), osteopontin (d) and 
osteocalcin (e) where dynamic group is normalized to perfusion only 
group at days 14 and 28. At specific time point, significant difference 
between groups is noted by ^ p<0.05. Within a specific group, 
significant difference between time points is noted by # p<0.05. When 










3.12 As-spun PVDF-TrFE scaffolds confocal images showing tissue cross-
section (scale bar = 500 µm) and distribution of collagen type I and 
osteocalcin proteins within that cross section cultured in osteogenic 
media, which underwent dynamic compression at day 28. Scaffolds 
without cells (control) and scaffolds with cultures stained for collagen 
type I (green), osteocalcin (green), F-actin (red) and nucleus (blue). 
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3.13 Annealed PVDF-TrFE scaffolds confocal images showing tissue cross-
section (scale bar = 500 µm) and distribution of collagen type I and 
osteocalcin proteins within that cross section cultured in osteogenic 
media, which underwent dynamic compression at day 28. Scaffolds 
without cells (control) and scaffolds with cultures stained for collagen 
type I (green), osteocalcin (green), F-actin (red) and nucleus (blue). 









3.14 PCL scaffolds confocal images showing tissue cross-section (scale bar = 
500 µm) and distribution of collagen type I and osteocalcin proteins 
within that cross section cultured in osteogenic media, which underwent 
dynamic compression at day 28. Scaffolds without cells (control) and 
scaffolds with cultures stained for collagen type I (green), osteocalcin 








A.1 Cell number on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE 
and PCL in chondrogenic cultures, which underwent dynamic 
compression and perfusion only in bioreactor conditions at days 12 and 
28. *p<0.05 significant difference between day 14 and 28. a p<0.05 
significant difference between as-spun PVDF-TrFE and annealed 
PVDF-TrFE in perfusion only at day 14. b p<0.05 significant difference 
between annealed dynamic and other dynamic groups at day 14. c 
p<0.05 significant difference between all dynamic groups at day 28 . d 











A.2 Glycosaminoglycans (GAGs) production on scaffolds of as-spun PVDF-
TrFE, annealed PVDF-TrFE and PCL in chondrogenic cultures, which 
underwent dynamic compression and perfusion only in bioreactor 
conditions at days 12 and 28. *p<0.05 significant difference between 
day 14 and 28. a p<0.05 significant difference between as-spun PVDF-
TrFE dynamic and other dynamic groups at day 14. b p<0.05 significant 
difference between annealed PVDF-TrFE perfusion and other perfusion 
groups at day 14. c p<0.05 significant difference between as-spun 
perfusion and other perfusion groups at day 28. d p<0.05 significant 
difference between annealed PVDF-TrFE dynamic and other dynamic 
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A.3 Collagen type II production on scaffolds of as-spun PVDF-TrFE, 
annealed PVDF-TrFE and PCL in chondrogenic cultures, which 
underwent dynamic compression and perfusion only in bioreactor 
conditions at days 12 and 28. *p<0.05 significant difference between 
day 14 and 28. a p<0.05 significant difference between as-spun PVDF-
TrFE dynamic and other dynamic groups at day 14. b p<0.05 significant 
difference between all perfusion groups at day 14. c p<0.05 significant 












A.4 Collagen type I production on scaffolds of as-spun PVDF-TrFE, 
annealed PVDF-TrFE and PCL in chondrogenic cultures, which 
underwent dynamic compression and perfusion only in bioreactor 
conditions at days 12 and 28. *p<0.05 significant difference between 
day 14 and 28. a p<0.05 significant difference between PCL dynamic 
and other dynamic groups at day 14. b p<0.05 significant difference 
between annealed PVDF-TrFE and other dynamic groups at day 28. c 
p<0.05 significant difference between all perfusion groups at day 28. d 
p<0.05 significant difference between as-spun PVDF-TrFE perfusion 












A.5 Aggrecan gene expression normalized to RPLPO (housekeeping gene) 
on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in 
chondrogenic cultures, which underwent dynamic compression and 
perfusion in bioreactor conditions at days 12 and 28. *p<0.05 significant 
difference between day 14 and 28. a p<0.05 significant difference 
between PCL dynamic and other dynamic groups at day 14. b p<0.05 
significant difference between PCL perfusion and annealed PVDF-TrFE 
perfusion at day 14. d p<0.05 significant difference between PCL 
dynamic and other dynamic groups at day 28. c p<0.05 significant 
difference between PCL perfusion and annealed PVDF-TrFE perfusion 
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A.6 SOX9 gene expression normalized to RPLPO (housekeeping gene) on 
scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in 
chondrogenic cultures, which underwent dynamic compression and 
perfusion in bioreactor conditions at days 12 and 28. *p<0.05 significant 
difference between day 14 and 28. a p<0.05 significant difference 
between PCL dynamic and other dynamic groups at day 14. b p<0.05 
significant difference between as-spun PVDF-TrFE and annealed 
PVDF-TrFE in perfusion condition at day 14. c p<0.05 significant 











A.7 Collagen type II gene expression normalized to RPLPO (housekeeping 
gene) on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and 
PCL in chondrogenic cultures, which underwent dynamic compression 
and perfusion in bioreactor conditions at days 12 and 28. *p<0.05 
significant difference between day 14 and 28. a p<0.05 significant 
difference between as-spun PVDF-TrFE dynamic and other dynamic 
groups at day 14. b p<0.05 significant difference between annealed 
PVDF-TrFE perfusion and PCL perfusion at day 14. c p<0.05 
significant difference between annealed PVDF-TrFE perfusion and 












A.8 Collagen type IX gene expression normalized to RPLPO (housekeeping 
gene) on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and 
PCL in chondrogenic cultures, which underwent dynamic compression 
and perfusion in bioreactor conditions at days 12 and 28. *p<0.05 
significant difference between day 14 and 28. a p<0.05 significant 
difference between as-spun PVDF-TrFE dynamic and other dynamic 
groups at day 14. b p<0.05 significant difference between annealed 
PVDF-TrFE perfusion and other perfusion groups at day 14. c p<0.05 
significant difference between as-spun PVDF-TrFE dynamic and other 
dynamic groups at day 28. d p<0.05 significant difference between 
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A.9 Chondroadherin gene expression normalized to RPLPO (housekeeping 
gene) on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and 
PCL in chondrogenic cultures, which underwent dynamic compression 
and perfusion in bioreactor conditions at days 12 and 28. *p<0.05 
significant difference between day 14 and 28. a p<0.05 significant 
difference between annealed PVDF-TrFE dynamic other dynamic 
groups at day 14. b p<0.05 significant difference between PCL dynamic 










A.10 Collagen type X gene expression normalized to RPLPO (housekeeping 
gene) on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and 
PCL in chondrogenic cultures, which underwent dynamic compression 
and perfusion in bioreactor conditions at days 12 and 28. *p<0.05 
significant difference between day 14 and 28. a p<0.05 significant 
difference between as-spun PVDF-TrFE dynamic and other dynamic 
groups at day 14. b p<0.05 significant difference between annealed 
PVDF-TrFE perfusion and other perfusion groups at day 14. c p<0.05 
significant difference between as-spun PVDF-TrFE dynamic and 
annealed dynamic at day 28. d p<0.05 significant difference between all 













A.11 Collagen type I gene expression normalized to RPLPO (housekeeping 
gene) on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and 
PCL in chondrogenic cultures, which underwent dynamic compression 
and perfusion in bioreactor conditions at days 12 and 28. *p<0.05 
significant difference between day 14 and 28. a p<0.05 significant 
difference between annealed PVDF-TrFE dynamic and as-spun PVDF-
TrFE dynamic, at day 28. c p<0.05 significant difference between PCL 










B.1 Cell number on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE 
and PCL in osteogenic cultures, which underwent dynamic compression 
and perfusion only in bioreactor conditions at days 14 and 28. a p<0.05 
significant difference between annealed PVDF-TrFE and other groups 
in dynamic at day 14. b p<0.05 significant difference between as-spun 
PVDF-TrFE and other perfusion groups at day 28. c p<0.05 significant 
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B.2 Alkaline phosphatase activity on scaffolds of as-spun PVDF-TrFE, 
annealed PVDF-TrFE and PCL in osteogenic cultures, which underwent 
dynamic compression and perfusion only in bioreactor conditions at 
days 14 and 28. a p<0.05 significant difference between PCL and other 
groups in dynamic at day 14. b p<0.05 significant difference between 
PCL perfusion and other perfusion groups at day 14. c p<0.05 
significant difference between PCL dynamic and other dynamic groups 
at day 28. d p<0.05 significant difference between PCL perfusion and 












B.3 Mineralization on scaffolds of as-spun PVDF-TrFE, annealed PVDF-
TrFE and PCL in osteogenic cultures, which underwent dynamic 
compression and perfusion only in bioreactor conditions at days 14 and 
28. *p<0.05 significant difference between day 14 and 28. a p<0.05 
significant difference between annealed PVDF-TrFE and other groups 








B.4 Osteocalcin production on scaffolds of as-spun PVDF-TrFE, annealed 
PVDF-TrFE and PCL in osteogenic cultures, which underwent dynamic 
compression and perfusion only in bioreactor conditions at days 14 and 






B.5 RUNX2 gene expression normalized to RPLPO (housekeeping) on 
scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in 
osteogenic cultures, which underwent dynamic compression and 
perfusion only in bioreactor conditions at days 14 and 28. *p<0.05 
significant difference between day 14 and 28. a p<0.05 significant 
difference between annealed PVDF-TrFE and other groups in dynamic 









B.6 Alkaline phosphatase gene expression normalized to RPLPO 
(housekeeping) on scaffolds of as-spun PVDF-TrFE, annealed PVDF-
TrFE and PCL in osteogenic cultures, which underwent dynamic 
compression and perfusion only in bioreactor conditions at days 14 and 
28. a p<0.05 significant difference between PCL and other groups in 
dynamic at day 14. b p<0.05 significant difference between PCL 
perfusion and other perfusion groups at day 14. c p<0.05 significant 
difference between annealed PVDF-TrFE dynamic and other dynamic 
groups at day 28. d p<0.05 significant difference between PCL 



















B.7 Collagen type I gene expression normalized to RPLPO (housekeeping) 
on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in 
osteogenic cultures, which underwent dynamic compression and 
perfusion only in bioreactor conditions at days 14 and 28. a p<0.05 
significant difference between PCL perfusion and other groups in 








B.8 Osteopontin gene expression normalized to RPLPO (housekeeping) on 
scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in 
osteogenic cultures, which underwent dynamic compression and 
perfusion only in bioreactor conditions at days 14 and 28. a p<0.05 
significant difference between annealed PVDF-TrFE dynamic and other 
groups in dynamic at day 14. b p<0.05 significant difference between 









B.9 Osteocalcin gene expression normalized to RPLPO (housekeeping) 
production on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE 
and PCL in osteogenic cultures, which underwent dynamic compression 
and perfusion only in bioreactor conditions at days 14 and 28. *p<0.05 
significant difference between day 14 and 28. a p<0.05 significant 
difference between annealed PVDF-TrFE dynamic and other groups in 













  CHAPTER 1
INTRODUCTION 
1.1 Clinical Application 
Osteoarthritis is the most prevalent cause of disability affecting nearly 27 million 
Americans [1], and its diagnoses are only expected to increase in the coming years. 
Osteoarthritis affects the patients’ quality of life by limiting physical movement, causing 
constant pain and affecting psychological well-being. The incidence is the highest in the 
older adult population (>= 60 years) and is diagnosed more in women (4-5 in 1000 
women) than in men (2-3 in 1000 men) [1]. Apart from its painful symptoms, 
osteoarthritis represents a significant financial burden on society where in 2009 alone 
knee and hip replacements cost $42.3 billion [1].  
Osteoarthritis is caused when extensive damage occurs to the articular cartilage, 
which later spreads to the underlying subchondral bone causing cystic lesions and is also 
known as osteochondral defects (Figure 1.1). If left untreated, osteochondral damage 
spreads to adjacent synovial joint lining and supporting connective tissues. It occurs from 
an imbalance between anabolic and catabolic activities of chondrocytes and other cells 
present within synovial joint.  The characteristic structural changes in osteoarthritis 
include the progressive loss of articular cartilage, subchondral bone cysts and formation 
of new bone at the joint margins (osteophytes) [2]. The tidemark, separating cartilage and 
underlying bone, begins to disappear and calcified cartilage becomes more prominent [3]. 
Damaged cartilage contains increased amounts of collagen types I and X and increased 




increased chondrocyte apoptosis which further hampers repair, and as a result, the 
compressive stiffness of cartilage decreases; therefore, affecting, metabolic activities and 
its electromechanical behavior [2].  
 






Osteochondral defects occurrence is most commonly reported for knee joints 
(femoral-tibial joints) but it can affect any joint in the body. For instance, lesions of the 
talus contribute to ankle fractures and sprains [5]. Pain and stiffness of the affected joint 
is the most commonly reported symptom. Some factors attributing to osteoarthritis are 
obesity, aging, repetitive trauma of joints especially in athletes, and genetic disposition 
[1, 5]. Current clinical therapy options include microfracturing, osteoarticular transfer 
and autologous chondrocyte transplantation (ACT). However, none of these therapies 
have been able to restore a normal cartilaginous surface. ACT is the only cell based FDA 
approved treatment for cartilage repair but has limited success. The chondrocytes have 
limited proliferation capacity and lose their phenotype during in vitro expansion; thus 
posing an issue to achieve adequate number of cells for transplantation [6]. Long-term 
studies have shown that cartilage formed with ACT is fibrocartilage, which is inferior in 
physiological and biomechanical properties when compared to healthy hyaline cartilage 
tissue [7]. None of the current treatment options have been able to completely restore an 
osteochondral defect, especially articular cartilage component. Therefore, there is 
urgency for alternative therapeutic options for addressing this clinical need.  
1.2 Cartilage 
Cartilage is a flexible tissue, providing support in various areas of the body. There are 
three main types of cartilage: fibrocartilage, elastic cartilage and hyaline cartilage. 
Hyaline cartilage is the most abundant and is found in articular cartilage, coating the 
foremost region of an osteochondral defect [5]. Cartilage tissue consists of water, 




Additionally, it is an avascular tissue lacking blood supply, nerves and lymphatic vessels 
interspersed with single cell type, the chondrocytes [9]. Chondrocyte synthesizes 
collagens and proteoglycans, which form the extracellular matrix (ECM) for articular 
cartilage.  
The collagens provide structural and elastic strength. Of the collagens, collagen 
type II, a homotrimer composed of α1 (II) chain is the most abundantly produced (80% 
of collagens) in articular cartilage [8]. The remaining collagens include collagen types III, 
V, VI, IX, XI, XII which are believed to play a role in the intermolecular interaction and 
modulation of collagen type II [5, 8]. Aggrecan is a proteoglycan composed of many 
sulfated glycosaminoglycans (GAGs) such as chondroitin sulfates and keratin sulfates, 
which have high density of negative charges on its surface [5]. These negative charges 
attract water, which gets absorbed and retained into the mesh made up of aggrecan, 
GAGs and collagens. This property renders articular cartilage its ability to resist high 
compressive forces while increasing flexibility during movement [8].  
 
Figure 1.2 A) Osteochondral tissue showing different zones of cartilage B) Features of 
different zones of cartilage tissue.                                                                                  
Source [10]. 
 
The articular cartilage is separated into different zones where each zone has 




and challenging tissue to repair (Figure 1.2). The four zones are (1) superficial zone, (2) 
middle zone, (3) deep zone and (4) calcified zone. The superficial zone has the smallest 
collagen fiber diameter consisting of tightly packed collagen fibers arranged in parallel to 
the articular surface and flattened chondrocytes lying tangential to these collagen fibers 
[10]. The superficial zone features enable smooth, frictionless movement of joints while 
resisting compressive forces. The middle zone, also the largest zone, has abundant 
proteoglycans and obliquely arranged collagen fibers interspersed with chondrocytes 
having rounded morphology [5, 8, 10]. These properties cause the middle zone to have a 
high compressive modulus, which facilitates recovery from impact. In the deep zone, the 
cells and collagen fibers are oriented perpendicularly to the articular cartilage’s surface 
and are anchored in the underlying subchondral bone [5]. The deep zone has the least 
number of chondrocytes and proteoglycans but has a much higher compressive modulus 
than the middle zone. The bottom most part of the deep zone has a thin line known as 
tidemark, indicating the transition from the deep zone to calcified zone. The calcified 
zone plays an important role as an interface between cartilage and bone for maintaining 
joint function [5].   
Articular cartilage provides multiple biophysical cues to chondrocytes in its 
unique environment where cartilage has electrically charged tissue components and depth 
dependent mechanical properties. It has been previously demonstrated that flow of free 
electrolytes (Na+, K+, Cl-) in surrounding interstitial water past the fixed negatively 
charges on proteoglycans influences the electrochemical behavior of cartilage [11]. These 
free flowing ions affect the water content, cartilage swelling behavior but also ion 




phenomenon is known as streaming potentials. Cartilage becomes electrically polarized 
under compressive loads and produces electrical potentials due to the flow of charged 
ions across negatively charged proteoglycans in and out of the ECM [2, 9, 12]. 
Conversely, application of electrical potential or current to cartilage can produce 
deformation in the tissue [2]. Based on these observations, ECM of cartilage is 
considered a mechanical signal transducer where joint loading results in multiple 
biophysical signals.   
1.3 Subchondral Bone  
Bone is a hard tissue composed of 35% of collagen, mostly collagen type I and 65% of an 
inorganic calcium salt, mostly hydroxyapatite. Its main function is to provide structural 
support required for movement. Bone continually remodels which is a dynamic process 
coordinated by cells such as osteoblasts (bone-producing cells) and osteoclasts (bone 
resorbing cells), hormones and enzymes [13]. Once an osteoblast has matured and 
becomes encased in its own secreted ECM, it is called an osteocyte, a terminally 
differentiated bone cell. Bone contains a vast vasculature network providing nutrients and 
assists in crosstalk with other tissues [14]. Bone continually takes up, stores and releases 
calcium into the blood to maintain homeostasis [13]. Unlike cartilage, bone has the 
ability to regenerate and self-repair to some extent. However, a person’s age, activity 
level and type of mechanical loading significantly influences bone remodeling and self-
repair.  
The area underneath cartilage’s calcified zone is the subchondral bone that 




subchondral bone is composed of bony lamella and underneath is the trabeculae [5].  The 
trabecula is extensively vascularized and contains nutrients for both itself and the 
overlying articular cartilage [14]. It has been well established that there exists a crosstalk 
between the joint cartilage and subchondral bone through some channels where 
biochemical signals are exchanged throughout the two tissues [14]. The subchondral bone 
plays a critical role in biomechanical function of the joint where it absorbs shocks and 
heals micro-fractures while maintaining joint shape due to its larger surface area and 
lower modulus of elasticity than cartilage [5]. The subchondral bone plate has non-
uniform thickness and density; as a result, the actual mechanical strength varies at 
different points of this tissue [5]. Therefore, it remains challenging to repair the 
subchondral bone layer.  
Similar to cartilage, bone is known to produce electrical potentials under 
compressive loads and is called a piezoelectric tissue. Piezoelectricity is a phenomenon 
where a material is capable of converting mechanical strain into electrical potential and 
the reverse is also true where the application of electrical potential can cause stress-
induced deformation in the material.  Bone piezoelectric phenomenon has been attributed 
to collagen, which exists in an highly organized fiber bundle and is tightly packed against 
one another [13]. Electrical potentials were recorded from dry bone, demineralized dry 
bone but not from decollagenated dry bone samples indicating the importance of collagen 
for its electrical behavior [15]. The stress-generated electrical potentials were created by 
the shear loading of collagen in human femur bone specimens [13]. Furthermore, 
individual collagen type I fibrils have been demonstrated to be piezoelectric under shear 




hypothesized that bone’s electrical behavior may be resulting from a combination of 
streaming potential and its inherent piezoelectric behavior. Streaming potential in bone 
arises when bone is loaded and interstitial fluid within bone gets squeezed out of its pores 
and interacts with the fixed charges of hydroxyapatite and collagen molecules producing 
surface charges [17]. Piezoelectric collagen may further contribute to the magnitude of 
surface charges resulting in electrical potential during compression loading [17].  
It has been speculated that bone piezoelectric properties affects repair and 
remodeling of bone tissue, and some studies have demonstrated that mechanically 
deformed or actively remodeling bone produces electrical current in vivo [15, 18].  
Additionally, the amplitude of electrical potentials were shown to be dependent on the 
rate and magnitude of bone loading while the polarity was dependent on the direction of 
the deformed bone [15]. Similar to cartilage, bone is considered a mechanical transducer 
where joint loading results in multiple biophysical cues. Over the years bone’s electrical 
behavior and response of bone cells to different forms of electric stimulations has been 
well established in many published in vitro studies, which has contributed to the 
development of electrical stimulators for healing bone fractures clinically [19]. 
1.4 Osteochondral Tissue Engineering  
Tissue engineering is an emerging field of novel therapeutic strategies to treat damaged 
or diseased tissues. The conventional approach is to engineer natural or synthetic 
materials into scaffolds and combine them with cells and/or growth factors to generate 
healthy tissue that will repair, replace and/or restore the diseased tissue while mimicking 




contributed immensely to the understanding of the individual tissue structures, 
mechanical properties and biology. Osteochondral tissue engineering applies bone and 
cartilage tissue engineering principles to the development of osteochondral constructs. 
Though the progress in the design and development of osteochondral constructs has come 
a long way, still there is a need for improvement. Some of the challenges in 
osteochondral tissue engineering are that the cartilage and the underlying subchondral 
bone have significantly different physical structures, compositions and mechanical 
properties that make it challenging to mimic these characteristics.  Based on these 
features, the design criterion for osteochondral tissue engineered constructs has been 
defined [5, 10]. The scaffold is expected to have mechanical properties mimicking 
cartilage but also the underlying bone (compressive, tensile and shear), adequate porosity 
to allow transport of nutrients and waste removal and support host tissue integration with 
the scaffold, support cell survival and promote biochemical properties such as GAGs and 
collagen production. Many tissue engineered osteochondral constructs have been 
successful in achieving biochemical composition similar to that of native cartilage but 
have failed to achieve native mechanical properties [2].  With these parameters as 
guidelines, scaffolds have been designed as single phase, or bilayered materials. A single-
phase scaffold is composed of the same material, which is preformed to fit a defect. 
Bilayered design is a composite incorporating two or more different materials to address 
the cartilage and bone components separately. Additionally, a third material may be 
incorporated as an interface between bone and cartilage layers.   
In order to mimic similar physical and mechanical features of cartilage and bone, 




naturally or developed synthetically. Some of the commonly used natural polymers for 
cartilage are collagen, chitosan, GAGs, alginate and poly (hydroxyalkanoates) [20]. 
These polymers offer flexibility to adapt different shapes, are biocompatible due to the 
presence of molecular domains, which guide cell attachment and growth, are 
biodegradable and have elastomeric properties. For instance, agarose scaffolds have been 
extensively used due to its hydrogel properties with the ability to retain water similar to 
cartilage [21]. Additionally, hydrogels support transport of cells and nutrients. The major 
disadvantages of using natural polymers are its limited mechanical properties, 
immunogenicity, purification issues and producing them in large quantities. Similarly, 
Synthetic polymers including but not limited to poly(lactic acid), poly(lactic-co-glycolic 
acid) and polycaprolactone offer wide range of chemistries, processing conditions and 
ability to modulate mechanical properties [10]. The fabrication can be accomplished at a 
larger scale and is a highly reproducible process, which is important for clinical demands. 
Inorganic materials such as hydroxyapatite, tricalcium phosphates (TCP) and bioglass 
have been widely used in bone tissue engineering [22]. These materials have 
demonstrated excellent osteoconductivity and osteoinductivity in vitro and in vivo studies 
[23, 24]. Though ceramics exhibit suitable compressive stiffness, but they are brittle and 
not suitable under mechanical loading conditions of an osteochondral joint. Using these 
materials alone or in combination with other materials, engineered scaffolds are then 
combined with different cell types (chondrocyte, stem cells) and/or growth factors to 
evaluate tissue repair in vitro or in vivo [22, 23]. Using this approach, many strategies are 




1.5 Cell Source 
Tissue engineered constructs are often combined with a cell type to further enhance 
osteochondral repair but also facilitate host tissue integration. Many cell types have been 
proposed for cartilage and bone tissue engineering applications. For cartilage repair, the 
obvious choice are the chondrocytes harvested from load bearing joints but other 
cartilaginous tissues such as outer ear, ribs and nasal septum have also been investigated 
[25]. Many studies have indicated chondrocytes being conducive for regenerating 
functional cartilage. However, load-bearing chondrocytes are found in few numbers 
within cartilage and other sources, which is not optimal for clinical demands. 
Furthermore, chondrocytes tend to lose its phenotype and dedifferentiate in vitro cultures 
and during expansion further limiting its usage [26]. Additionally, chondrocytes-
harvesting procedure utilizes harsh reagents, which may further impact chondrocyte 
behavior.  
Due to aforementioned complications with chondrocyte harvest and usage, 
mesenchymal stem cells (MSCs) have become a promising cell source due to their ability 
to self-renew, and differentiate into various cell types including osteoblasts and 
chondrocytes [27]. MSCs can also be obtained from different tissue sources such as 
adipose tissue, umbilical cord, periosteum and dental pulp [28, 29]. Of these, bone 
marrow derived MSCs are extensively studied for bone and cartilage repair [30]. MSCs 
have been well characterized for their immunophenotype, multipotent capabilities and 
their proliferative capacity [31-33].
 
These progenitor cells have been cultured up to 15 
passages as well as cryopreserved and still have the capacity to differentiate and 




potential to be valuable as a readily available and abundant source of cells in the tissue 
engineering and regenerative medicine fields. Furthermore, studies have demonstrated 
that the use of allogeneic MSCs can successfully repair bone and cartilage tissues in 
many animal models without provoking an adverse immune response[37-39]. Similar to 
chondrocytes, MSC usage does come with a caveat especially for cartilage tissue 
engineering. MSCs have been successful in expressing enhanced mature cartilage 
markers, but studies also indicate that MSCs continue to differentiate towards 
hypertrophy and end with bone formation. This observation indicates its natural pathway 
of endochondral ossification process [27]. Therefore, MSCs may need additional 
stimulation to control its differentiation especially to chondrocytes and retain this 
phenotype in in vitro culture but also in vivo.   
1.6 Growth Factors 
Growth factors have become an essential part of osteochondral tissue engineering. In 
osteochondral environment, the growth factors are naturally produced by the body and 
can regulate cell proliferation and differentiation while maintaining tissue homeostasis.  
These growth factors can be delivered in culture medium or via scaffolds [40, 41]. In 
cartilage tissue engineering, growth factors commonly used include transforming growth 
factor- β (TGF-β), insulin growth factor (IGF), basic fibroblast growth factor (bFGF), 
and bone morphogenic proteins (BMPs) [42]. Of these, TGF- β1 and TGF- β3, has been 
the most investigated for MSC chondrogenesis and for maintaining chondrocyte 
phenotype in vitro cultures. Use of TGF- β has been shown to enhance collagen type II 




4 and 7 are known to play a critical role in bone-healing by stimulating MSCs 
differentiation towards an osteoblast [44]. A detailed review on growth factors during 
chondrogenesis and osteogenesis have been described elsewhere [41, 43].  
1.7 Mechanical and Electrical Stimulus  
Increasing experimental evidence has supported the application of mechanical stimulus 
and its importance in regulating chondrogenesis and osteogenesis in early development, 
adult skeletal tissue maintenance and repair [45]. Bioreactors are designed to facilitate 
three-dimensional tissue growth by allowing mass transfer of nutrients and waste removal 
while providing controlled physical and chemical cues to cells that mimic in vivo 
conditions. Bioreactor studies have established that compression and shear forces are the 
two dominant physical cues that effect cartilage and bone tissues [5]. Many studies have 
utilized bioreactor systems to apply compressive loads on pellets, cell-laden scaffolds or 
bone and cartilage explants as in vitro model to understand cartilage and bone repair 
mechanisms [46, 47]. Dynamic compression at parameters ranging from of 0.01-3Hz at 
0-15% strain, duration of signal (intermittent and continuous) and culture period from 48 
hours up to 8 weeks have been the most explored and shown to have an effect on the 
production of collagen and proteoglycan [48]. Mechanically stimulated MSCs also have 
been shown to exhibit chondrocyte like characteristics as determined by gene expression 
in short term cultures when compared to statically cultured MSCs [49]. Direct perfusion 
bioreactors allow the control of cell culture medium flow rate, which applies fluid shear 
forces to the tissue constructs while increasing transfer to waste and nutrient during 




enhance cell density in the scaffolds center, cell proliferation and differentiation of MSCs 
towards chondrogenesis or osteogenesis [5]. Current studies are focused on identifying 
the optimal mechanical stimulation parameters and the single bioreactor design that could 
be effective for the osteochondral tissue repair.  
Electrical stimulus has also been shown to influence bone and cartilage repair due 
to aforementioned native tissues’ electrochemical properties.  Many electrical stimulus 
devices are clinically available for bone repair and is discussed in detail elsewhere [50]. 
Two modes of electrical stimulation are most commonly studied in vitro (1) direct 
current, in which field is directly applied to cells usually in a custom built chamber via 
agar salt bridges in culture and (2) capacitive coupling where a homogenous electric field 
is created between two parallel layers of metal plates that are separated by a small 
distance [2]. Direct current application of 5mA has shown to differentiate MSCs into 
chondrocytes and enhanced proliferation and formation of cartilage [2]. Brighton et al. 
have shown that the application 20 mV/cm via capacitvely coupling enhanced osteogenic 
or chondrogenic matrix proteins gene expression in osteoblasts and chondrocytes in vitro 
cultures [51, 52]. Electrical stimulus was shown to increase extracellular calcium influx 
via voltage gated calcium channels and an increase in activated cytoskeletal calmodulin 
in both electrically stimulated osteoblasts and chondrocyte. The current studies are 
focused on understanding the mechanisms behind electrical stimulus and optimal 




1.8 Thesis Motivation 
Poly (vinylidene fluoride) (PVDF) and its copolymer, synthesized using PVDF and 
trifluoroethylene (PVDF-TrFE), are attractive for biomimetic osteochondral tissue 
engineering applications due to its piezoelectric properties, which can be exploited in cell 
cultures under mechanical and electrical stimulus. Unprocessed PVDF exists in a non-
piezoelectric phase, which needs to be mechanically stretched under electrical poling to 
transform into piezoelectric β-phase. PVDF-TrFE, however, exists in an all-trans polar 
crystalline polymer consisting of β-phase and does not require any physical 
modifications.  PVDF is a FDA approved polymer for biomedical application in sutures 
[53]. PVDF-TrFE has been well characterized for its piezoelectric properties in field of 
sensors and transducers [54].  Recent studies have demonstrated biocompatibility and 
established multiple tissue engineering applications using PVDF-TrFE as a scaffold. For 
instance, composite of PVDF-TrFE and barium titanate membranes were able to induce 
cell proliferation and neo bone formation when implanted under tibiae of male rabbits by 
day 21 [55]. Aligned, electrospun PVDF-TrFE scaffolds have been shown to support the 
differentiation of neural stem cells into a neuron-like phenotype [56]. Additionally, 
PVDF-TrFE based pressure sensor are being investigated for catheter applications [57].  
In order to mimic the structure of the natural extracellular matrix, PVDF-TrFE 
was fabricated into a fibrous scaffold using the electrospinning technique.  The micron to 
nanoscale fiber is a beneficial structural feature for cell adhesion and growth due to its 
large surface-to-volume and high aspect ratios resulting from the smallness of the 




known piezoelectric characteristics, which is a property found in native cartilage and 
bone extracellular matrix and offers ease in processing into scaffolds.  
1.9 Objectives 
The goal of this research was to evaluate piezoelectric PVDF-TrFE polymer as a scaffold 
to induce MSCs differentiation to form bone and cartilage tissues in vitro for its potential 
application for osteochondral defect repair. PDVF-TrFE fibrous scaffolds were fabricated 
to mimic the extracellular matrix physical structure and were compared to a non-
piezoelectric control. This project sought to characterize the material properties of the 
electrospun PVDF-TrFE and, for the first time, demonstrate MSC differentiation on 
PVDF-TrFE scaffolds and characterize the piezoelectric effect. This study hypothesizes 
that piezoelectric scaffolds will promote chondrogenic and osteogenic differentiation of 
MSCs. Specific aims are listed as followed:  
1. To fabricate and characterize electrospun PVDF-TrFE scaffolds. 
2.   To evaluate the chondrogenic and osteogenic differentiation of human        
mesenchymal stem cells (MSCs) on fibrous piezoelectric scaffolds using a 




  CHAPTER 2
FABRICATION AND CHARACERIZATION OF  
PIEZOELECTRIC PVDF-TRFE SCAFFOLDS  
2.1 Introduction 
Tissue engineering offers an alternative approach by combining a biomaterial with cells 
for the repair of damaged tissues. The biomaterial is designed to mimic the native tissue 
physical structure but also provides chemical cues for the desired cell function. The 
electrospinning technique has been widely applied for scaffold development for bone and 
cartilage tissue engineering applications [59]. Electrospinning is a dynamic process 
where an electric field is applied to an ejecting polymer solution resulting in the 
formation of fibers, which are collected as a non-woven fibrous mat on a grounded plate. 
Electrospun scaffolds can mimic the fibrous extracellular matrix and provide a large 
surface area, which has been shown to influence cell attachment and protein adsorption 
[60]. Depending on the application, scaffolds properties such as porosity, fiber size and 
orientation can be customized by modifying the electrospinning process parameters and 
polymer concentration.  
Smart biomaterials such as piezoelectric scaffolds are interesting due to its ability 
to generate charge in response to minute deformations, where the generated charge has 
been shown to influence cells behavior [61]. A commonly used piezoelectric polymer, 
poly(vinylidene fluoride) (PVDF), and its copolymer, poly(vinylidene fluoride – 
trifluoroethylene) (PVDF-TrFE) has been known to exhibit  superior piezoelectric 
properties among other polymers. PVDF is a semi crystalline polymer that can exist in 




phase [62]. In PVDF, the non-piezoelectric, α-phase is most readily formed during 
crystallization from melt below 160oC. Its polymer chains conformation is arranged in 
trans-gauche-trans-gauche (TGTG), where net dipole moment is zero due to its 
antiparallel arrangement of fluoride atoms along the carbon backbone.  The β-phase can 
be achieved by mechanical stretching followed by electric field poling of the α-phase 
[62]. However, copolymerization of PVDF with TrFE results in a copolymer that readily 
crystallizes from melt into the β-phase crystal, consisting of polymer chains arranged in 
all trans (TTTT) conformation, which results in net dipole moment (Figure 2.1) [63]. 
More importantly, PVDF-TrFE does not require additional mechanical stretching and 
electrical poling to achieve piezoelectric properties, and PVDF-TrFE exhibits much 
higher crystallinity than PVDF. The electrical property of PVDF-TrFE depends on the 
molar content of VDF and TrFE affects the crystal structure and crystallinity [63]. 
Additionally, PVDF-TrFE allows ease in processing into scaffolds for potential tissue 
engineering applications. Previous studies have reported the fabrication of electrospun 
PVDF and PVDF-TrFE fibers based nanogenerators and characterized its piezoelectric 
properties [64]. These studies have reported voltage outputs ranging from 100 mV to 1 V 
from PVDF-TrFE fibers based sensors when subjected to different compressive pressures 










Figure 2.1 Chemical Structure of poly(vinylidene fluoride – trifluoroethylene) (PVDF-
TrFE).                                
Source [63]. 
 
Bone and cartilage have been known to display electrical behavior when 
subjected to compressive deformations [2, 15]. Therefore, the application of piezoelectric 
PVDF-TrFE polymers as a scaffold may allow to mimic bone and cartilage extracellular 
matrix, which provides electrical signals relevant for biological activity. PVDF-TrFE 
biocompatibility is well established and has been shown to influence differentiation of 
neural stem cells into neurons [66]. Additionally, PVDF-TrFE/barium titanate composite 
films were shown to support bone formation in a calvarial defect in murine model [67]. In 
this chapter, PVDF-TrFE scaffolds were fabricated by electrospinning and as-spun 
PVDF-TrFE scaffolds were heat-treated to achieve annealed PVDF-TrFE scaffolds. Both 
the scaffolds were characterized for the formation of β-phase, crystallinity and 
piezoelectric properties. Additionally, human mesenchymal stem cells (MSCs) 
differentiation towards cartilage (chondrogenic) and bone (osteogenic) lineages on these 
scaffolds was examined to establish that the scaffolds are supportive of these lineages. 
Studies were performed in standard culture conditions. As a non-piezoelectric control, 




cell studies. It is hypothesized that piezoelectric scaffolds will enhance the differentiation 
of MSCs along chondrogenic and osteogenic lineages over PCL.  
2.2 Methods 
2.2.1 Scaffold Fabrication 
Fabrication of fibrous scaffolds was accomplished using electrospinning technique. The 
electrospinning setup consisted of solution of 25 wt./vol.% poly (vinylidene difluoride – 
trifluoroethylene) (65/35, PVDF-TrFE, Solvay Solexis, NJ) solution in methyl ethyl 
ketone (Fisher Scientific, NJ). The polymer solution was transferred to a 10 mL syringe 
(BD, Fisher Scientific) fitted with a stainless steel needle. The syringe was placed on a 
syringe pump (Harvard Apparatus, MA) with a set flow rate of 15 mL/hr and a high 
voltage power supply (Gamma High Voltage Research, USA) was used to apply 25-28 
kV to the needle. The electrospun fibers were collected on a grounded stainless steel plate 
placed at 35 cm distance away from the tip of the needle. The fibers were spun at room 
temperature (~ 20 - 23oC) with 15-20% humidity for 15 minutes for thin scaffolds with 
~100 - 300 µm thickness or 90 minutes for thicker scaffolds with ~3 - 4 mm. The 
scaffolds were placed under vacuum for at least 48 hours before further processing. The 
scaffolds used without further processing were labeled as-spun PVDF-TrFE scaffolds. 
The annealed PVDF-TrFE scaffolds were achieved by placing the as-spun scaffolds in 
the oven at 135oC for 96 hours followed by ice water quenching for few seconds. The 
scaffolds were allowed to dry completely before being used further tests. As a non-




scaffolds were fabricated with 15 wt./wt.% PCL in methylene chloride (Fisher Scientific, 
USA).  
2.2.2 Scaffold Morphology  
Fiber morphology, fiber diameter and inter-fiber space were characterized using scanning 
electron microscopy (SEM, LEO 1530 Gemini, Germany).  Briefly, samples were sputter 
coated with gold palladium and viewed using an accelerating voltage of 3-5 kV and a 
working distance of 4 - 8 mm. Image J software (National Institutes of Health, MD) was 
used for all measurements from SEM images using previously reported protocols [68]. 
Briefly, diameters of at least 80 fibers, 16 each from five samples per group, were 
measured. Porosity of dry samples was calculated using the following formula [69]: 
                                          Porosity   % = (1−   !!"#
!!"#
)×100         (1) 
where ρmat is the density of the scaffold, which was determined by dividing the mass of 
the scaffolds by the total volume of scaffold. The raw density, ρraw, for PVDF-TrFE and 
PCL is 1.78 and 1.145 gcm-3, respectively. Results are reported as mean ± standard 
deviation.  
2.2.3 Tensile Mechanical Properties 
Tensile tests were performed using Instron 3342 single column system (Instron, MA) to 
determine Young’s modulus and Ultimate tensile stress for all electrospun scaffold 
groups. The scaffolds were cut into 70 x 10 mm strips with a testing area of 40 x 10 mm. 
For each scaffold group, n = ten samples were tested at a rate of 40 mm/min. Each 
sample’s thickness was measured at three locations along the length of the strip (at the 




were sterilized with 100% ethanol (Fisher Scientific) for 20 minutes and later rinsed with 
PBS prior to the mechanical testing. Results are reported as mean ± standard deviation.  
2.2.4 Compression Mechanical Properties 
Unconfined compression tests were performed using dynamic mechanical testing device 
(DMTA-4, Rheometric Scientific, NJ) system to determine compressive Young’s 
modulus. The scaffolds were punched in to cylinders with 6 mm in diameter and 3 mm in 
height. For each scaffold group, n = ten samples were tested at a strain rate of 0.001 % 
per sec. All the scaffolds were sterilized with 100% ethanol (Fisher Scientific) for 20 
mins and later rinsed with PBS prior to the mechanical testing. Results are reported as 
mean ± standard deviation.  
2.2.5 Water Contact Angle Measurements  
Wettability of the three scaffold groups was performed using sessile drop water contact 
measurement using a goniometer built in house. The scaffolds (6 mm diameter) were 
mounted on to a glass slide with the help of double-sided tape. The water (5 mL) was 
dropped on the scaffold and the contact angle was recorded (n = 20 per scaffold). Results 
are reported as mean ± standard deviation.  
2.2.6 Thermal Properties 
Differential scanning calorimetric (DSC; Mettler Toledo Polymer, USA) was used to 
determine the temperature at which permanent piezoelectricity transitions to induced 
piezoelectricity also called Curie temperature (Tc), melting temperature (Tm) and Heat of 
Fusion (ΔHf) for all samples. The samples underwent a heat-cool-heat temperature cycle 




nitrogen purge. The DSC data presented were representative of three independent runs. 
The crystallinity (Xc ) of the samples was calculated using the following equation:  
     (2) 
where Hfs is the measured heat of fusion for melting of sample, and Hft is the heat of 
fusion for 100% crystalline PVDF-TrFE, which is 45 Jg-1 [66]. Results are reported as 
mean ± standard deviation.  
2.2.7 Fourier Transform Infrared Spectroscopy (FTIR) 
Fourier transform infrared spectroscopy (FTIR) analysis was performed for as-spun and 
annealed PVDF-TrFE electrospun scaffolds (Perkin Elmer FTIR-ATR 100 series, USA), 
and the data presented are representative of three independent samples and runs. The 
samples were scanned from 400 to 1500 cm-1 with a resolution of 4 cm-1 and total of 40 
scans. Previously described procedures were used to determine the relative fraction of β-
phase present in each sample [65]. Using characteristic absorption bands of α and β 
phases at 532 cm-1 and 846 cm-1, respectively, and assuming these absorption bands 
follow Beer-Lambert law with absorption coefficients of Kα = 6.1 x 104 and Kβ = 7.7 x 
104 cm2/mol, the fraction of β-phase can be calculated using the following equation:  
	   	   (3) 
	  
where Xα and Xβ are the crystalline mass fractions of the α and β phases and Aα and Aβ 
correspond to absorption bands at 532 cm-1 and 846 cm-1, respectively. Results are 














2.2.8 X-ray Diffraction Analysis (XRD) 
X-ray diffraction (XRD) was performed for as-spun and annealed PVDF-TrFE 
electrospun samples using an X’pert Pro Diffractrometer (Philips PW3050/60, 
Netherlands). The samples were irradiated with monochromatized Cu Ka (l= 0.154 nm) 
X-ray source with a step size (2q) of 0.02 and scan step time (s) of 1.0. The operating 
voltage and current used were 45 kV and 40 mA, respectively. The samples were scanned 
in the 2q range of 15 to 45 degrees.  
2.2.9 Piezo Force Microscopy (PFM) 
Piezo force microscope (PFM) was used to evaluate piezoelectric property of an 
individual fiber for all three groups. Briefly, few fibers were electrospun on sputter 
coated glass slides with gold palladium. The topography of the fibers was examined using 
an Asylum Research MFP-3D AFM and Olympus ac 240TS cantilever in tapping mode. 
The piezoresponse was examined using high voltage PFM module of MFP-3D AFM and 
AC 240TM cantilever mode of a tetrahedral silicon tip coated with platinum/titanium for 
conductivity. The piezoresponse was imaged by applying ac driving voltage ranging from 
1.1 to 8.4V without a dc bias. Polarization was switched by applying a sequence of dc 
bias and forming a triangle wave.  Between each voltage step (~100 steps total), the dc 
bias was stepped back to zero. [70] 
2.2.10 Force Sensors 
The scaffolds ranging approximately ~100 - 200 µm thick scaffolds were sandwiched 
between conducting copper tapes, which were attached to electrodes. The electrodes were 
connected to an oscilloscope (Tektronix DPO4000B, Beaverton, OR) for recording the 




right under the compression platen. In order to avoid over loading texture analyzer and to 
protect sensor, a PDMS film (3 cm x 1.5 cm x 1.5 mm thick) was used as a spacer on the 
sensor. Each sensor was tested at 1, 5 and 10 Hz (sinusoidal waveform) under 
approximately 10, 15 and 20% deformations (based on total height of sensor plus spacer). 
 
Figure 2.2 Force transducers testing setup (a) force transducer (scale bar = 63.5 mm), (b) 
cross-section of force transducer and  (c) schematic of the testing device setup with force 
transducer. 
 
2.2.11 Scaffold Sterilization 
All scaffolds were cut into 6 mm diameter disks using a biopsy punch (Miltek, PA). The 
scaffolds were sterilized with 100% ethanol (Fisher Scientific) for 20 mins and later 
rinsed four times with PBS. Prior to cell seeding, scaffolds were transferred to a non-
adherent, 96-well polypropylene plate and were kept hydrated in PBS (Fisher Scientific).   
2.2.12 Human Mesenchymal Stem Cells (MSCs) Isolation and Culture 
Human MSCs were isolated from commercially available whole bone marrow aspirates 
collected from the superior iliac crest of the pelvis of male donors of ages ranging from 
Insulating tape Copper tape 
PVDF-TrFE fibers 
Conducting wire 
Testing module, without insulation 












18-30 (Lonza Biosciences, MD). The isolation method has been previously reported in 
detail [71]. The MSCs were plated on tissue culture polystyrene flasks (Nunc, NY) and 
maintained at 37°C and 5% CO2 in control medium consisting of Dulbecco’s Minimum 
Essential Medium (DMEM; Invitrogen, NY) supplemented with 10% fetal bovine serum 
(Hyclone, UT), and 1% antibiotic-antimycotic (Invitrogen).  
2.2.13 Chondrogenic Differentiation 
The cells were trypsinized at 70 - 80% confluent, washed and resuspended in serum-free 
chondrogenic medium.  The chondrogenic medium consisted of high-glucose DMEM 
(Invitrogen) supplemented with 1 mM sodium pyruvate (Sigma Aldrich), 0.17 mM 
ascorbic acid-2-phosphate (WAKO Pure Chemicals, VA), 0.1 mM dexamethasone 
(Sigma Aldrich), 0.35 mM L-proline (Sigma Aldrich), 4 mM L-Glutamine (Invitrogen), 
1% antibiotic-antimycotic (Invitrogen), 1% ITS + premix (BD), and 10 ng/mL TGF-b3 
(ProSpecbio, NJ). MSCs were seeded at 1x105 cells/cm2 on each scaffold and plates were 
incubated at 370C, 5% CO2, and 85% RH. The media was replaced every 3-4 days and 
samples were incubated for up to 28 days. For assays, samples  (n = five) were collected 
at Days 1, 14 and 28. The study was repeated with at least two different donors (male, 
ages 18-30).   
2.2.14 Chondrogenic Gene Expression 
At each time point, scaffolds (n = five) were pooled, rinsed in PBS and lysed in RLT 
buffer (Qiagen, USA) using a tissue homogenizer (Cole Parmer, IL).  RNA was isolated 
using RNeasy Mini Kit (Qiagen) using manufacturer’s protocol. The RNA concentration 
and integrity was performed using a nanodrop (Fisher Scientific) and spectrophotometric 




polymerase chain reaction (RT-PCR) was performed using Real-Time PCR instrument 
(Stratagene, Mx3000P). RNA was reversed transcribed into complimentary DNA and 
amplified using One Step QuantiTect SYBR Green RT-PCR Kit (Qiagen) and gene 
specific forward/reverse primers (Qiagen) according to manufacturer’s instructions. 
Briefly, the reverse transcription step ran for 30 min at 500C, followed by a PCR initial 
activation step for 15 min at 950C. Forty amplification cycles were performed, consisting 
of cDNA denaturation for 15 seconds at 940C, annealing for 30 seconds at 550C, and 
extension for 30 seconds at 720C. A melting curve analysis was included for each 
reaction. Samples were assayed in triplicates and the values were first normalized to the 
housekeeping gene RPLPO (ribosomal protein, large, PO) in the same samples (ΔCT) 
[72]. The mRNA expression of focal adhesion kinase (FAK), collagen type II, 
chondroadherin, SOX9, aggrecan and ribosomal large protein (RPLPO, house-keeping 
gene) were evaluated.  
2.2.15 Cell Proliferation  
Cell proliferation was determined by DNA quantification using the PicoGreen® ds DNA 
assay (Invitrogen). Standards were prepared with a known number of MSCs. Standards 
and samples were lysed in either 3M guanidine chloride (chondrogenic samples; Sigma 
Aldrich) or 0.1% triton X-100 (osteogenic samples; Sigma Aldrich). An aliquot of cell 
lysate was mixed with an equal volume of diluted PicoGreen reagent in 1X TE buffer 
(1:200, Invitrogen). Fluorescence intensity was measured with a microplate reader 
(FLX800, Biotek Instruments, VT) at 480 nm excitation and 520 nm emission. A 
standard curve correlated the fluorescence intensity of standards to known cell number. 
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Based on the standard curve, unknown samples’ cell number was determined. Results are 
reported as mean ± standard deviation.  
2.2.16 Glycosaminoglycans (GAGs) Assay 
An aliquot of samples prepared for cell proliferation assay was used to quantify sulfated 
GAGs using Blyscan Assay kit (Biocolor, UK). The standards using chondroitin 4-sulfate 
were prepared at different concentrations ranging from 0.25 – 5.0 µg. An aliquot of the 
sample was reacted with dye reagent (1,9-dimethylmethyleneblue , DMMB) for 30 mins. 
The samples were centrifuged and any unbound reagent was discarded. Bound dye was 
mixed with dissociation reagent and quantified using spectrophotometer (Emax, 
Molecular Devices, CA) at 656 nm. The unknown GAGs were determined using the 
standard curve. Results are reported as mean ± standard deviation.  
2.2.17 Osteogenic Differentiation 
The cells were trypsinized at 70 - 80% confluent, and resuspended in general medium 
(GM) or osteogenic inductive medium (OS). GM consisted of low-glucose DMEM 
(Invitrogen) supplemented with 1% antibiotic-antimycotic (Invitrogen), and 10% fetal 
bovine serum (Hyclone). OS medium consisted of GM medium supplemented with 10 
mM β-glycerophosphate (Sigma Aldrich), 50 µM L-ascorbic acid-2-phosphate (WAKO) 
and 100 nM of dexamethasone (Sigma Aldrich). MSCs were seeded at 3x104 cells/cm2 on 
each scaffold and plates were incubated at 370C, 5% CO2, and 85% RH. The media was 
replaced every 2 days and samples were incubated for up to 28 days. For assays, samples  
(n = five) were collected at Days 7, 14, 21 and 28. The study was repeated with at least 
two different donors (male, ages 18-30).   
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2.2.18 Alkaline Phosphatase Activity Assay 
Alkaline phosphatase (AP) activity was measured by quantifying the conversion of para-
nitrophenyl phosphate (Sigma Aldrich) to para-nitrophenol (p-NP). Samples were 
prepared by lysing cells with 0.1% Triton X-100 and incubated at 37oC for 30 minutes. 
The absorbance was read at 405 nm with a microplate spectrophotometer (Emax, 
Molecular Devices). The AP activity was normalized to cell number determined from cell 
proliferation assay and expressed as nmol of p-NP/min/cell. Results are reported as mean 
± standard deviation.  
2.2.19 Mineralization Assay 
Mineralization of the extracellular matrix was measured using a quantichrom calcium 
detection kit (Bioassay Systems, CA, USA). Briefly, the samples were homogenized and 
digested in 0.5 N HCL overnight at room temperature. The calcium standards were 
prepared at various concentrations. Samples and working solution was mixed and 
incubated for 3 minutes. The absorbance was read at 570 nm with a microplate 
spectrophotometer (Emax, Molecular Devices). Results are reported as mean ± standard 
deviation.  
2.2.20 Immunofluorescence Staining for Confocal Imaging 
The harvested samples were washed with PBS and fixed in 4% paraformaldehyde (Sigma 
Aldrich) overnight at 4oC. The samples were permeablized with 0.1% triton-x100 for 15 
minutes at room temperature. A blocking serum consisting of 5% donkey serum (Sigma 
Aldrich) or rabbit serum (Sigma Aldrich) in 1% bovine serum albumin (BSA, Fisher 
Scientific) was used to treat samples for 1 hour at room temperature to avoid nonspecific 




mouse antihuman collagen type II (EMD Millipore, USA) or rabbit antihuman collagen 
type I antibody (EMD Millipore) in 1% BSA overnight at 4oC For osteogenic samples, 
the samples were incubated in 1:1000 rabbit antihuman collagen type I or rabbit 
antihuman osteocalcin antibody (EMD Millipore) in 1% BSA overnight at 4oC. After a 
series of PBS washes, the samples were then incubated in 1:200 secondary antibody 
(donkey antimouse IgG or rabbit antigoat IgG in 1% BSA, Invitrogen) along with 1:100 
rhodamine phalloidin (Invitrogen) to view actin for 1 hour at room temperature. The 
nucleus was stained with 4',6-diamidino-2-phenylindole (DAPI, Invitrogen). 
2.2.21 Statistical Analysis 
SPSS 20.0 software (SPSS Inc., IL, USA) was used for statistical analysis of all 
quantitative data. For each donor, statistical analysis was performed based on the number 
of samples collected at each time point for each assay. The results were initially tested for 
normality (Shapiro Wilk test) and Levene’s equal variance test. Two-way Analysis of 
Variance (ANOVA) and the post hoc multiple comparison using Tukey’s tests were 
applied.  Probability (p) values < 0.05 were considered statistically significant.  
2.3 Results 
2.3.1 Scaffold Morphology  
As shown in Figure 2.3, micron sized fibers were achieved using electrospinning 
technique for both as-spun and annealed PVDF-TrFE and PCL. The measured fiber 
diameters and inter-fiber space are shown in Table 2.1. Both of the PVDF-TrFE scaffolds 




diameters ranging between 4 – 13 µm. The significant difference was not noted in fiber 
diameters, inter-fiber spacing and overall porosity between the three scaffold groups. 
Additionally, water drop contact angle measurements were performed to assess 
hydrophobicity and no differences were noted between the three scaffold groups.  
 
Figure 2.3 SEM images of as-spun PVDF-TrFE (a) & (d), annealed PVDF-TrFE (b) & 
(d) and PCL (c) & (f) at 500X and 2000X. Scale bar at 500X = 100 µm and 2000X = 10 
µm. 
 










As-spun PVDF-TrFE 5.9 ± 2.0 81.1 ± 33.8 93 133.6 ± 2.1 
Annealed PVDF-TrFE 6.9  ± 1.7 89.3 ± 28.6 92 134.3 ± 4.3 
PCL 9.8 ± 3.0 62.2 ± 33.4 88 135.0 ± 3.5 
     
2.3.2 Mechanical Properties 
A summary of Young’s modulus and ultimate tensile stress for all scaffold groups are 
reported in Table 2.2. There were no significant differences observed for Young’s 
modulus between as-spun and annealed PVDF-TrFE and PCL groups. Annealing PVDF-
TrFE did increase Young’s modulus but it was not statistically significant. The ultimate 
tensile stress was significantly lower for PCL scaffolds compared to PVDF-TrFE 
(a) (b) (c) 




scaffolds. The compressive Young’s modulus was significantly lower for as-spun PVDF-
TrFE group compared to annealed PVDF-TrFE and PCL groups.  
 
Table 2.2 Mechanical Properties for Electrospun Scaffolds 






As-spun PVDF-TrFE 4.0 ± 1.2 0.71 ± 0.08 5.6 ± 2.3b 
Annealed PVDF-TrFE 5.3 ± 2.3 0.90 ± 0.28 10.7 ± 5.7 
PCL 5.8 ± 1.0 0.48 ± 0.06a 16.7 ± 4.6 
Values represent mean ± standard deviation 
a p<0.05 where PCL scaffolds are significantly different PVDF-TrFE groups 
b p<0.05 where as-spun PVDF-TrFE group is significantly different from annealed PVDF-TrFE and 
PCL groups.  
 
2.3.3 Thermal Properties 
The DSC was performed to determine the melting temperature (Tm) and heat of fusion of 
the electrospun scaffolds. Figure 2.4 shows the endothermic curves and Table 2.3 
summarizes the results from DSC analysis. The crystallinity (%Xc) was calculated using 
equation 2. PCL scaffolds had the lowest Tm as compared to both of the PVDF-TrFE 
scaffolds. The Tm was significantly lower for as-spun PVDF-TrFE than annealed PVDF-
TrFE scaffolds. Similarly, crystallinity was significantly lower for PCL and as-spun 
PVDF-TrFE than annealed PVDF-TrFE scaffolds. Both PVDF-TrFE scaffolds 
demonstrated a curie temperature (Tc). Annealed PVDF-TrFE scaffold’s Tc was 





Figure 2.4 DSC spectrums for (i) as-spun PVDF-TrFE and (ii) annealed PVDF-TrFE. (b) 
PCL scaffolds. 
 








As-spun PVDF-TrFE 113.1 ± 0.3a 147.4 ± 0.4a 44.6 ± 4.3a 
Annealed PVDF-TrFE 125.1 ± 0.5a 151.5 ± 0.2 a 63.8 ± 2.3a 
PCL - 60.3 ± 0.7 a 36.5 ± 2.0a 
Values represent mean ± standard deviation 
a p<0.05 where all groups different 
 
2.3.4 Fourier Transform Infrared Spectroscopy (FTIR) 
FTIR spectrum (Figure 2.5) of both PVDF-TrFE scaffolds exhibited primarily β-phase 
peaks at 508, 846 and 1285 cm-1. The α-phase peaks at 532, 612, 765, 796, 854, 870 and 
970 cm-1 were not appreciable. The annealed PVDF-TrFE had significantly higher β-
phase fraction of 75 ± 3.2% than as-spun PVDF-TrFE, 64 ± 2.8%. Similar analysis was 
not performed for PCL scaffolds since these peaks are specific to piezoelectric phases 
present in PVDF-TrFE materials, and PCL is a non-piezoelectric polymer.  




























Figure 2.5 FTIR spectra of (a) as-spun PVDF-TrFE and (b) annealed PVDF-TrFE fibers.  
 
2.3.5 X-ray Diffraction (XRD)  
X-ray diffraction spectrums of both PVDF-TrFE scaffolds are shown in Figure 2.6. Both 
of the scaffolds spectrums consistently showed peaks characteristic of β-phase at 2θ = 
20o.  The as-spun PVDF-TrFE had a small shoulder off peak at ~2θ = 18o characteristic 
of α-phase, which overlapped with the β-phase peak. In annealed PVDF-TrFE scaffolds, 
two smaller peaks were observed at ~2θ = 37o and 42o indicating some presence of α-
phase.  
 


















Figure 2.6 XRD spectra of (a) as-spun PVDF-TrFE and (b) annealed PVDF-TrFE fibers. 
 
2.3.6 Piezo Force Microscopy (PFM) 
A comparison of local piezoresponse loops for single point obtained from PFM for as-
spun PVDF-TrFE, annealed PVDF-TrFE and PCL fibers are shown in Figure 2.7. 
Characteristic voltage butterfly loops were observed for both PVDF-TrFE scaffolds in the 
“on” state, indicating that fiber deformation occurred when voltage was applied. In the 
“off” state, applied voltage is stepped back to 0 V and electric interactions between AFM 
tip and fiber was noted. Both PVDF-TrFE fibers demonstrated amplitudes changes during 
“off” state indicating the inherent piezoelectric behavior of fibers. PCL fiber did not 
demonstrate distinct voltage butterfly loop in “on” state and only noise was detected in 
“off” state , thus confirming its the non-piezoelectric property.  












Figure 2.7 Piezo force microscopy (PFM) voltage butterfly loops for as-spun PVDF-
TrFE (a, d), annealed PVDF-TrFE (b, e) and PCL fibers (c) in “on” and “off” state. 
 
2.3.7 Force Sensors 
Force sensors were fabricated with as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL 
scaffolds for measuring electrical output under dynamic compression loads at varying 
frequencies. It was noted that voltage output increased with increasing deformation levels 
and frequencies for both PVDF-TrFE scaffolds. Annealed PVDF-TrFE scaffolds had the 
highest voltage output than as-spun PVDF-TrFE. PCL did not generate any electrical 
















Table 2.4 Electrical Output from Force Sensors  
   Electrical output 








1 10% 20 2.3 mV 117 mV 
1 15% 100 6.9 mV 168 mV 
1 20% 200 8.4 mV 324 mV 
5 10% 20 4.4 mV 866 mV 
5 15% 100 20 mV 1.5 V 
5 20% 200 27.5 mV 2.9 V 





	   	   	  
	  
Figure 2.8 Confocal images of cells in CCM+ medium where cells were placed on as-
spun PVDF-TrFE, annealed PVDF-TrFE and PCL scaffolds for up to 28 days. Cultures 
stained for F-actin (red), nucleus (blue), and collagen types I and II (green). Scale bar = 
50 µm. 
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2.3.8 Cell Morphology of Chondrogenic Cultures 
The confocal images confirmed cells attached to all scaffolds as evidenced by intense F-
actin staining at all time points as shown in Figure 2.8. As early as day 1, cells formed 
aggregates on all scaffolds. Cells produced collagens type I and II as early as day 14 on 
all scaffolds. Cells on as-spun PVDF-TrFE appeared to produce the most collagen type II 
as shown by the intense staining at day 28 as compared to other groups.  
2.3.9 Chondrogenic Biochemical Assays 
Cell proliferation was determined over the course of 28 days in culture as shown in 
Figure 2.9. The results showed an increase in cell number at days 14 and 28 when 
compared to Day 1. At day 14, PCL was significantly different than PVDF-TrFE 
scaffolds. No significant differences were noted between days 14 and 28 for each scaffold 
group. 
 
Figure 2.9 Cell proliferation shown as fold change since day 1 in CCM+ medium where 
cells were placed on as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL scaffolds for 
up to 28 days. a p<0.05 significant difference between days 1 and 14 and b p <0.05 

























Glycosaminoglycan (GAGs), an early extracellular matrix marker, was 
determined at day 1, 14 and 28 as shown in Figure 2.10. Results are shown as total GAGs 
(Figure 2.10a) and normalized GAG per cell (Figure 2.10b). Results demonstrate an 
increase in total GAGs by day 14 and later decrease by day 28 (p<0.05). No significant 
differences were noted between as-spun and annealed PVDF-TrFE scaffolds at all time 
points. The cells on PCL had significantly lower amounts of total GAGs than annealed 
PVDF-TrFE scaffolds at day 14 (p < 0.05).  When normalized to cell number no 
significant differences were detected between scaffolds and at all time points.  
 
Figure 2.10 Glycosaminoglycan production (a) Total GAG per scaffold and (b) total 
GAGs normalized to cell number in CCM+ medium where cells were placed on as-spun 
PVDF-TrFE, annealed PVDF-TrFE and PCL scaffolds for up to 28 days. *p<0.05 
significant difference between groups, a p<0.05 significant difference between days 1 and 
14 and b p<0.05 significant difference between days 14 and 28 *p<0.05  
 
2.3.10 Chondrogenic Gene Expression 
Gene expression of chondrogenic markers was evaluated at days 1, 14 and 28 to monitor 
MSCs differentiation on all three scaffolds, as shown in Figure 2.11. Focal adhesion 
kinase (FAK), an indicator of cell attachment, was expressed by cells on all three 
scaffolds. At day 14, cells on PCL scaffolds had significantly higher FAK expression 


















































significantly increased for cells on as-spun PVDF-TrFE but remained unchanged on other 
scaffolds. SOX9 gene expression, which maintains chondrogenic potential, was 
significantly different between annealed PVDF-TrFE and PCL group at day 1 (p<0.05).  
At day 14, SOX9 expression on PCL scaffolds decreased significantly from day 1 
(p<0.05). By day 28, cells on both as-spun and annealed PVDF-TrFE scaffolds had a 
significantly higher SOX9 expression than the PCL group (p<0.05), which was further 
decreased. Aggrecan expression was highest at day 1 for cells on as-spun PVDF-TrFE 
when compared to annealed PVDF-TrFE and PCL groups (p<0.05). However, at day 14 
aggrecan expression significantly decreased for all groups compared to day 1 (p<0.05). 
By day 28, cells on the annealed PVDF-TrFE had the highest aggrecan expression 
followed by as-spun PVDF-TrFE and lowest for PCL group (p<0.05). Mature 
chondrogenic markers collagen type II and chondroadherin were significantly different 
for all three groups at day 28, where as-spun PVDF-TrFE scaffolds had the highest 








Figure 2.11 Gene expression for cells in CCM+ medium where cells were placed on as-
spun PVDF-TrFE, annealed PVDF-TrFE and PCL scaffolds for up to 28 days. (a) Focal 
adhesion kinase (FAK) (b) SOX9 (c) aggrecan (d) collagen type II (e) chondroadherin 
where *p<0.05 significant difference between groups, a p<0.05 significant difference 
between days 1 and 14, b p<0.05 significant difference between days 14 and 28 and c 
p<0.05 day 28 is significantly different from days 1 and 14.  
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Figure 2.12 Confocal images of cells in OS medium where cells were placed on as-spun 
PVDF-TrFE, annealed PVDF-TrFE and PCL scaffolds for up to 28 days. Cultures stained 
for F-actin (red), nucleus (blue), and collagen type I or osteocalcin (green). Scale bar = 50 
µm. 
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2.3.11 Cell Morphology of Osteogenic Cultures 
Confocal images (Figure 2.12) confirmed cell attachment to all scaffolds and expression 
of cytoskeleton F-actin. Samples were stained for early osteogenic marker, collagen type 
I and osteocalcin, a mature osteogenic differentiation marker. All the scaffolds stained for 
collagen type I and osteocalcin from day 14 onwards.  
2.3.12 Osteogenic Biochemical Assays 
The osteogenic cell proliferation results, as shown in Figure 2.13, indicated an increasing 
trend in cell number from day 7 to 21 for all scaffolds. However, the PCL group had a 
significant increase in cell number at days 14 and 21 when compared to day 7 (p<0.05). 
By day 28, all scaffolds showed a slight decrease in cell number. No significant 
differences were observed between scaffolds at all time points.  
 
Figure 2.13 Cell number for cells in OS medium for up to 28 days. a p<0.05 significant 
difference between days 7 and 14, b p<0.05 significant difference between days 14 and 
21. 
 
The alkaline phosphatase activity, an early osteogenic differentiation marker, was 
























2.14. Results indicated a significantly higher alkaline phosphatase activity for all scaffold 
groups at day 14 as compared to day 7. Significant differences were noted between as-
spun and annealed PVDF-TrFE groups where the annealed group was highest. Alkaline 
phosphatase activity significantly decreased at days 21 and 28 as compared to day 14.  
 
Figure 2.14 Alkaline phosphatase activity normalized to cell number on as-spun and 
annealed PVDF-TrFE and PCL scaffolds in OS medium for up to 28 days. *p < 0.05 
significant difference between groups, a p<0.05 significant difference between days 7 and 
14, b p<0.05 significant difference between days 14 and 21 and c p<0.05 significant 
difference between days 14 and 28. 
 
Calcium or mineralization of the extracellular matrix, was quantified for all 
scaffolds at days 7, 14, 21 and 28, as shown in Figure 2.15. A significant increase in 
mineralization was observed at all time points for all scaffold groups. Only at day 28, 
cells on as-spun PVDF-TrFE scaffolds had significantly lower calcium levels than the 


































 b   b  b 






Figure 2.15 Calcium or mineralization of the extracellular matrix for cells on as-spun and 
annealed PVDF-TrFE and PCL scaffolds in OS medium for up to 28 days. *p < 0.05 
significant difference between groups, # p<0.05 significant difference between all time 
points.  
2.4 Discussion 
The aim of this study was to characterize the material properties of the PVDF-TrFE 
scaffolds and assess MSCs differentiation potential along chondrogenic and osteogenic 
lineages on these scaffolds. Additionally, PCL scaffold was evaluated as a non-
piezoelectric control in biological studies. Studies confirmed that PVDF-TrFE scaffolds 
contained the piezoelectric β-phase, but a significant increase in crystallinity and relative 
β-phase fraction occurred due to annealing. All the scaffolds were supportive of 
osteogenic and chondrogenic differentiation, however, chondrogenic differentiation was 
enhanced on PVDF-TrFE scaffolds as indicated by increased GAG production and 
expression of chondrogenic markers i.e. aggrecan, collagen type II and chondroadherin. 
Some differences were noted for osteogenic differentiation where cells on annealed 

























TrFE but no differences in biochemical markers were detected between piezoelectric 
materials and non-piezoelectric control for this lineage in static culture conditions. 
Electrospinning parameters such as applied voltage, solvent and polymer 
concentration have an impact on fiber uniformity and size. In this study, 15% wt/wt PCL 
was chosen as the polymer concentration with methylene chloride as the solvent for 
achieving scaffolds with a similar fiber diameter range as 25% wt/vol PVDF-TrFE 
scaffolds. Although PVDF-TrFE scaffolds have relatively uniform fiber diameters, PCL 
scaffolds consisted wider range of fiber sizes as noted by the large standard deviation. 
One reason could be the differences in boiling points between the solvents used. Methyl 
ethyl ketone (MEK, 79.6oC) has a higher boiling point than methylene chloride (39oC). 
As a result, MEK evaporates much faster during electrospinning than methylene chloride. 
Similar findings have been previously reported where mixture of nano and micron size 
fiber diameters where achieved for PCL scaffolds [73]. This phenomenon is common 
during electrospinning where an ejecting polymer solution becomes highly charged and 
experiences electrostatic forces, which causes repulsion of charges on its surface aids in 
elongating the fiber [62]. Additionally, polymer concentration affects the viscoelastic 
forces by hampering fiber elongation. Therefore, this polymer jet becomes highly 
unstable, and undergoes whipping and bending motion, which results in nano and micron 
fiber diameters.  
Annealing is commonly used with PVDF-TrFE films to enhance degree of 
crystallinity, which directly influences the electrical behavior of PVDF-TrFE. In this 
study, 135oC was chosen as the annealing temperature, which was between Curie 




PVDF-TrFE scaffolds. Previous work with PVDF-TrFE films has suggested that 
choosing annealing temperature above Tc but below Tm increases the grain size and 
crystallinity of orientation of β-phase while polymer chains align parallel to the substrate 
with polarization dipole moment perpendicular to the substrate [63, 74]. This study’s 
findings are comparable with previous study findings and have demonstrated the 
significant increase in Tc, Tm and crystallinity for annealed electrospun PVDF-TrFE 
scaffolds compared to as-spun PVDF-TrFE scaffolds.  
Force sensors were fabricated to assess electrical output when scaffolds were 
subjected to compressive loads, and the annealed PVDF-TrFE reported the highest 
electrical output ranging from 117 mV to 2.9 V. Since the scaffolds were collected in a 
randomly oriented manner, one can speculate that there may be cancellation of net dipole 
moments, which are hypothesized to be perpendicularly oriented to polymer fiber from 
electrospinning [65] and may not produce voltage output . However, when annealed 
scaffolds were subjected to dynamic deformations, voltage outputs were noted, which 
increased with applied frequency and deformation. In this study, voltage outputs from as-
spun PVDF-TrFE ranged from 2.25 mV to 99 mV depending on the applied frequency 
and deformation. These findings were significantly higher than previously reported where 
as-spun PVDF-TrFE scaffolds voltage output was ~ 2.5 mV at 27 Hz [75]. More recent 
studies have reported higher electrical output from as-spun PVDF-TrFE scaffolds when 
subjected to different ranges of pressures and frequencies. For instance, Mandal et al. 
have demonstrated pressure sensor fabricated by electrospinning of randomly oriented 
PVDF-TrFE fibers with output voltage of about 400 mV when subjected to 0.2 MPa 




electrospinning of aligned PVDF-TrFE fibers with output ranging from 0.79 – 1.3 V 
under 0.1-1 Pa compressive stress at 1 and 2 Hz [65]. These recent studies further 
confirm that application of low pressures can stimulate electrical output from PVDF-
TrFE fibers. In the current study, relatively high forces were applied because the 
instrument settings did not allow the modification of applied forces. Therefore, a PDMS 
substrate was used to dampen the excessive applied force.  
The differences noted in electrical properties can be attributed to composition of 
PVDF-TrFE, which in this study was 65/35 wt% compared to 75/25 wt% in previous 
studies. The electrical properties and the formation of crystal phases depend on PVDF-
TrFE ratio where higher ratio results in higher electrical output and crystallinity. This 
may also be the reason for observing smaller α-phase peaks in annealed PVDF-TrFE 
scaffolds. Additionally, the current study used MEK as the solvent, which was different 
from prior studies where N,N-dimethylformamide (DMF) and butan-2-one was used, 
which may impact the β-phase formation and electrical properties. Nevertheless, PFM 
results further confirmed the piezoelectric behavior of both PVDF-TrFE scaffolds 
compared to PCL group. However, PFM analysis performed in this study was qualitative 
thus the calculations for piezoelectric constant, d33, which quantifies the deformation of 
these fibers when subjected to electric field, was not made.  
Interestingly, there were no significant differences observed for Young’s modulus 
between all three scaffolds. Although annealed PVDF-TrFE had the highest ultimate 
tensile strength but this was not statistically significant when compared to as-spun PVDF-
TrFE and PCL scaffolds. Randomly oriented electrospun fibers have anisotropic 




may not be the best method for obtaining materials true Young’s modulus. Mechanical 
testing of single fiber has been suggested as an alternative method for assessing polymer 
properties [77]. Nevertheless, bulk tensile method does provide an understanding of 
electrospun polymer strength and differences between different chemistries.  A previous 
study of electrospun PVDF-TrFE scaffolds had higher Young’s modulus than the ones 
reported in this study [56]. The fiber diameters achieved in this study were much larger 
along with larger inter-fiber space than the previous study, which may have contributed 
to the differences noted in Young’s modulus. Electrospinning smaller fiber diameter 
results in a denser collection of fibers and smaller inter-fiber space, which has been to 
enhance mechanical properties [78, 79].  
The chondrogenic differentiation of MSCs on as-spun and annealed PVDF-TrFE 
was enhanced over the PCL control, as indicated by biochemical and gene markers. . 
PCL scaffolds have been widely used for cartilage and bone tissue engineering for in 
vitro applications [73, 80-82]. In order to compare piezoelectric scaffolds with a non-
piezoelectric scaffold, PCL was the best choice due to similar mechanical properties and 
ability to fabricate similar fiber size and morphology as PVDF-TrFE fibers.  All the three 
scaffold groups supported MSC attachment and similar proliferation trends in both 
chondrogenic and osteogenic cultures over 28 days. For the chondrogenic cultures, 
confocal images confirm the attachment and aggregation of cells as early as day 1 
indicating the early condensation of MSCs and initiation of cell-cell contact similar to 
early embryonic development [6, 83]. PVDF-TrFE groups both supported chondrogenic 
differentiation as confirmed by early GAG production, which was significantly higher 




cultures demonstrate a peak in GAG production between days 11-19 days after which 
GAG accumulation decreases while collagen type II production increases [84]. SOX9, a 
transcription factor is expressed in early chondrogenesis, which regulates and maintains 
chondrocyte phenotype for differentiating MSCs and later expression of collagen type II 
gene [84].   In this study, both PVDF-TrFE groups had higher SOX9 expression than the 
PCL group at days 14 and 28 indicating higher MSCs chondrogenic differentiation 
potential at the gene level. Furthermore, Collagen type II expression was up-regulated on 
as-spun PVDF-TrFE group and was significantly higher than annealed PVDF-TrFE and 
PCL groups. The confocal images further confirmed an increase in collagen type II 
production by intense protein staining at days 14 and 28 on the as-spun PVDF-TrFE 
scaffolds than other scaffolds, especially PCL. Additionally, chondroadherin gene 
expression overlaps with collagen type II expression appearing later in the process of 
extracellular matrix assembly [84]. In this study, chondroadherin similar to collagen type 
II was detected from day 14 onwards and peaking at day 28. Both the piezoelectric 
scaffolds demonstrated significantly higher chondroadherin expression, especially the as-
spun PVDF-TrFE group, as compared to the  PCL group. Although the culture conditions 
were performed in static conditions, these findings suggest a role of piezoelectric activity 
where piezoelectric fibers may be sensitive to cell-induced deformations affecting MSCs 
differentiation behavior. It is well known that differentiated cells adhere, contract, and 
migrate/crawl in and along substrates while deforming the matrix [85]. In in vitro 
conditions, cells can contract their matrices up to 1-3 mm [86]. At the molecular scale, 
matrix interaction and deformation by the cell occurs via focal adhesion complexes that 




generates to deform the matrix results in signal transduction cascades leading to 
activation of transcription factors that affect gene expression in the cell.
 
Engler et al. have 
demonstrated that MSCs are sensitive to matrix elasticity, which dictates its specific 
lineage. FAK gene is up regulated in early MSC condensation, down regulated in 
chondrocyte differentiation and later re-expressed during chondrocyte hypertrophy 
towards bone formation [68].  FAK gene expression results showed  a higher expression 
on the PCL group at day 14 but this later decreased by day 28. FAK expression for cells 
on PVDF-TrFE scaffolds continued to increase by day 28, which may indicate these cells 
are further differentiated on PVDF-TrFE scaffolds. Hypertrophic genes will be examined 
in Chapter 3.  Aggrecan gene expression was consistently higher on piezoelectric groups 
as compared to PCL group. Further confirming increased differentiation of MSCs on 
piezoelectric scaffolds than non-piezoelectric polymer, PCL.  
In osteogenic cultures, no significant differences were noted for early osteogenic 
marker, alkaline phosphatase activity, and mineralization between piezoelectric groups 
and PCL group. Previous studies have shown an effect of increased β-phase fraction on 
osteogenic differentiation of MSCs with nano sized PVDF fibrous scaffolds [62]. 
Similarly in this study, alkaline phosphatase activity was significantly higher for annealed 
PVDF-TrFE scaffold, which had a higher β-phase fraction than as-spun PVDF-TrFE. 
However, no differences were observed for mineralization between all scaffolds. The 
differences in fiber diameters of previously reported nano scale PVDF fibers [62] versus 
micron scale fibers in this study could have contributed to the observed trends noted in 
osteogenesis. It has been well-established that cell attachment and differentiation is 




fiber size increases, cells are not able to spread across multiple fibers and may sense large 
fibers as film [89], which can adversely affect osteogenesis.  
Previous cell studies with piezoelectric polymers such as PVDF have primarily 
been performed using films due to the feasibility of fabricating a non-piezoelectric 
control with similar chemistry as the piezoelectric group. These studies have shown 
variable response to the presence or lack of piezoelectric β-phase. However, PVDF-TrFE 
polymers are permanently piezoelectric polymer and it is not possible to obtain a non-
piezoelectric form. Therefore, PCL was chosen as a non-piezoelectric polymer as a way 
of identifying the piezoelectric effect on MSC differentiation. The next set of studies 
described in Chapter 3 will aim to demonstrate MSCs differentiation towards 
chondrogenic and osteogenic lineages on piezoelectric materials when stimulated under 





  CHAPTER 3
CHONDROGENIC AND OSTEOGENIC DIFFERENTIATION OF MSCS ON 
PVDF-TRFE SCAFFOLDS IN A PERFUSED COMPRESSION  
BIOREACTOR SYSTEM 
3.1 Introduction 
In order to repair osteochondral defects, the requirements of bone, cartilage and the bone-
cartilage interface must be taken into account. As a potential scaffold, piezoelectric 
PVDF-TrFE offers intriguing properties due to its capability of generating electrical 
potentials under mechanical deformation as shown in Chapter 2, which has the potential 
to influence MSCs differentiation. In literature, it’s been well established that bone and 
cartilage respond to compressive mechanical stimulus but also become electrically 
polarized under compressive loads [2, 11, 15]. Grodzinsky et al. demonstrated the 
generation of electrical potentials from circular plugs of articular cartilage when 
subjected to compressive loading. Similarly, electrical potentials were also observed 
when knee joint explants where exposed to mechanical force up to 800 N [9]. The 
electrical activity of cartilage has been attributed to the movement of ions within 
interstitial fluid under compression flows over negatively charged proteoglycan 
molecules resulting in the generation of an electrical current [9]. Similarly, bone’s 
piezoelectricity was demonstrated when stress-generated electrical potentials were 
created by the shear loading of collagen in human femur bone specimens [13]. 
Furthermore, individual collagen type I fibrils have been demonstrated to be piezoelectric 
under shear deformation using piezo force microscopy (PFM) technique [16]. It has been 




tissue, and some studies have demonstrated that mechanically deformed or actively 
remodeling bone produces electrical current in vivo [15, 18]. Additionally, electrical 
stimulus on osteoblasts and chondrocytes in vitro cultures has been shown to enhance 
osteogenic or chondrogenic matrix protein gene expression. Application of alternating 
electrical fields of 20 mV/cm up-regulated aggrecan and type II collagen gene expression 
in chondrocytes [90], and human MSCs were shown to differentiate into osteoblasts, 
while expressing enhanced levels of alkaline phosphatase and collagen type I [91].  
Previous studies with PVDF-TrFE have been with films where PVDF-TrFE 
combined with barium titanate was investigated for bone regeneration in vitro with 
osteoblasts [92] and in vivo rat calvarial bone defects [67]. These studies confirmed 
biological compatibility and increased bone regeneration. However, a three dimensional 
environment is essential for facilitating cell growth and tissue formation if it is to be 
clinically relevant. In this study, PVDF-TrFE scaffolds were prepared by electrospinning 
and MSC differentiation towards chondrogenic and osteogenic lineages on these 
scaffolds was examined using a cyclic compression with continuous perfusion bioreactor 
system.  By applying cyclic compression in culture, we can examine cell behavior when 
the PVDF-TrFE scaffolds are deformed and therefore, activating the piezoelectric activity 
of the scaffold. Comparisons were made between as-spun PVDF-TrFE, annealed PVDF-
TrFE and PCL (non-piezoelectric control). We hypothesize that piezoelectric scaffold 
undergoing dynamic compression will enhance chondrogenesis and osteogenesis 





3.2  Materials and Methods 
3.2.1 Scaffold Fabrication 
Fabrication of fibrous scaffolds was accomplished using electrospinning technique. The 
electrospinning setup consisted of solution of 25 wt./vol.% poly (vinylidene difluoride – 
trifluoroethylene) (65/35, PVDF-TrFE, Solvay Solexis, NJ) solution in methyl ethyl 
ketone (Fisher Scientific, NJ). The polymer solution was transferred to a 10 mL syringe 
(BD, Fisher Scientific) fitted with a stainless steel needle. The syringe was placed on a 
syringe pump (Harvard Apparatus, MA) with a set flow rate of 15 mL/hr and a high 
voltage power supply (Gamma High Voltage Research, USA) was used to apply 25-28 
kV to the needle. The electrospun fibers were collected on a grounded stainless steel plate 
placed at 35 cm distance away from the tip of the needle. The fibers were spun at room 
temperature (~ 20 - 23oC) with 15-20% humidity for 90 minutes for thicker scaffolds 
with ~3 - 4 mm. The scaffolds were placed under vacuum for at least 48 hours before 
further processing. The scaffolds used without further processing were labeled as-spun 
PVDF-TrFE scaffolds. The annealed PVDF-TrFE scaffolds were achieved by placing the 
as-spun scaffolds in the oven at 135oC for 96 hours followed by ice water quenching for 
few seconds. The scaffolds were allowed to dry completely before being used further 
tests. As a non-piezoelectric scaffold, polycaprolactone (PCL, MW 80000, Sigma 
Aldrich, USA) scaffolds were fabricated with 15 wt./wt.% PCL in methylene chloride 





3.2.2 Scaffold Sterilization 
All scaffolds were cut into 6 mm diameter disks using a biopsy punch (Miltek, PA, USA). 
The thickness of scaffold with ~ 3 mm were chosen for biological studies. The scaffolds 
were sterilized with 100% ethanol (Fisher Scientific, USA) for 20 mins and later air dried 
in sterile hood overnight. Each scaffold was transferred to sterile 5 mL polypropylene test 
tubes (BD) for cell seeding.  
3.2.3 Human Mesenchymal Stem Cells (MSCs) Isolation and Culture 
Human MSCs were isolated from commercially available whole bone marrow aspirates 
collected from the superior iliac crest of the pelvis of male donors of ages ranging from 
18-30 (Lonza Biosciences, MD). The isolation method has been previously reported [71] 
The MSCs (P3 or P4) were plated on tissue culture polystyrene flasks (Nunc, NY, USA) 
and maintained at 37°C and 5% CO2 in control medium consisting of Dulbecco’s 
Minimum Essential Medium (DMEM; Invitrogen, NY, USA) supplemented with 10% 
fetal bovine serum (Hyclone, UT, USA), and 1% antibiotic-antimycotic (Invitrogen).  
3.2.4 Bioreactor Systems Overview 
Two different bioreactor systems were used in these studies. One of the systems was 
capable of dynamic compressive loading and simultaneous perfusion (Cartigen 9-X, 
Instron TERM, MA) through nine different wells and holds up to 9 different samples. 
Cartigen 9-X bioreactor chamber is connected to a load cell (FUTEK, CA) that is 
connected to a control box and laptop computer with software program (TGT). The 
second system is capable of only perfusion through nine different wells (Perfusion Series; 




perfusion was achieved using Masterflex peristaltic pump systems (Masterflex L/S; Cole 
Parmer).  
3.2.5 Cell Seeding and Bioreactor Conditions 
The cells were trypsinized at 70 - 80% confluent, washed, counted using a 
hemocytometer and resuspended in control medium. After counting, 2.0 x 106 cells per 
mL cell suspension was prepared, and 500 µL of cell suspension was added to each 
scaffold in a test tube. Using a 21G sterile needle (Fisher Scientific) and 10 mL sterile 
syringe, vacuum was applied on sealed test tubes until cell suspension penetrated the 
scaffold and air bubbles were at minimum [93]. The test tubes were lightly capped and 
incubated at 37°C and 5% CO2 for at least 3 hours to allow cell attachment.  
For Day 0 cell count and imaging, samples (n = five per scaffold group) were 
harvested after 3 hours incubation period and prepared for cell count or imaging. 
Otherwise, scaffolds were transferred to bioreactor for differentiation studies. The 
samples for dynamic compressive loading (n = nine) were placed in its system, and the 
continuous perfusion flow rate in each was controlled at a rate of 0.5 mL/min and was 
applied for the duration of the experiment of 28 days. Next day (Day 1), the loading 
protocol was begun and consisted of 10% dynamic compressive strain (of scaffolds 
height) using a sinusoidal waveform at 1 Hz for 3 hours per day up to 28 days. Applied 
forces and platen displacement were monitored and recorded. Similarly, the samples for 
perfusion only (n = nine) were loaded in perfusion system, and the continuous perfusion 
flow rate in each was controlled at a rate of 0.5 mL/min and was applied for the duration 
of the experiment of 28 days. The total media volume used for each bioreactor was 200 




= four) and 28 (n = five) for tissue analysis. Each scaffold was rinsed in PBS, cut into 
four quarters, weighed and separated for different analytical techniques. The study was 
repeated with at least two different donors. The bioreactor conditions were the same for 
chondrogenic and osteogenic differentiation studies except the cell culture medium.  
3.2.6 Chondrogenic Differentiation 
The chondrogenic medium consisted of high-glucose DMEM (Invitrogen) supplemented 
with 1 mM sodium pyruvate (Sigma Aldrich), 0.17 mM ascorbic acid-2-phosphate 
(WAKO Pure Chemicals, VA, USA), 0.1 mM dexamethasone (Sigma Aldrich), 0.35 mM 
L-proline (Sigma Aldrich), 4 mM L-Glutamine (Invitrogen), 1% antibiotic-antimycotic 
(Invitrogen), 1% ITS + premix (BD), and 10 ng/mL TGF-b3 (ProSpecbio, NJ, USA).  
3.2.7 Osteogenic Differentiation 
Osteogenic medium consisted of control medium supplemented with 10 mM beta 
glycerophosphate (Sigma Aldrich), 50µM L-ascorbic acid-2-phosphate (WAKO) and 100 
nM of dexamethasone (Sigma Aldrich).  
3.2.8 Cell Proliferation  
Cell proliferation (n = four quarters per scaffold group per time point per condition) was 
determined by DNA quantification using the PicoGreen® ds DNA assay (Invitrogen). 
Standards were prepared with a known number of MSCs. Standards and samples were 
lysed in either 3Mguanidine chloride (chondrogenic samples; Sigma Aldrich) or 0.1% 
triton X-100 (osteogenic samples; Sigma Aldrich). An aliquot of cell lysate was mixed 
with an equal volume of diluted PicoGreen reagent in 1X TE buffer (1:200, Invitrogen). 




Instruments, VT) at 480 nm excitation and 520 nm emission. A standard curve correlated 
the fluorescence intensity of standards to known cell number. Based on the standard 
curve, unknown samples’ cell number was determined. Results are reported as mean ± 
standard deviation.  
3.2.9 Glycosaminoglycans (GAGs) Assay 
An aliquot of samples prepared for cell proliferation assay was used to quantify sulfated 
GAGs using Blyscan Assay kit (Biocolor, UK). The standards using chondroitin 4-sulfate 
were prepared at different concentrations ranging from 0.25 – 5.0 µg. An aliquot of the 
sample was reacted with dye reagent (1,9-dimethylmethyleneblue , DMMB) for 30 
minutes. The samples were centrifuged and any unbound reagent was discarded. Bound 
dye was mixed with dissociation reagent and quantified using spectrophotometer (Emax, 
Molecular Devices, CA) at 656 nm. The unknown GAGs were determined using the 
standard curve. Results are reported as mean ± standard deviation.  
3.2.10 Collagen Types I and II ELISA 
Solubilized collagen types I and II were quantified using separate ELISA kits (Chondrex, 
WA, USA). Prior to assay, collagens were solubilized in samples according to the 
manufacturers protocol. Briefly, the samples were homogenized and digested with 3M 
guanidine chloride to remove GAGs overnight on shaker at 4oC. Next day the samples 
were treated in acetic acid overnight in fridge to remove guanidine chloride. The samples 
were further digested at 10 mg/mL pepsin on shaker at 4oC for up to 6 days to solubilize 
collagens. For collagens quantification, the supernatant was diluted at 1:40 or 1:10 with 
dilution buffer. In the sample mixture, the collagen proteins were captured by polyclonal 




and streptavidin peroxidase. OPD and H2O2 were added to the mixture, and sulfuric acid 
was then added after 30 min to stop the reaction. The spectrophotometric absorbance of 
the mixture was measured at 490 nm. Results are reported as mean ± standard deviation.  
3.2.11 Alkaline Phosphatase Activity Assay 
Alkaline phosphatase (AP) activity was measured by quantifying the conversion of para-
nitrophenyl phosphate (Sigma Aldrich) to para-nitrophenol (p-NP). Samples were 
prepared by lysing cells with 0.1% Triton X-100 and incubated at 37oC for 30 minutes. 
The absorbance was read at 405 nm with a microplate spectrophotometer (Emax, 
Molecular Devices, CA, USA). The AP activity was normalized to cell number 
determined from cell proliferation assay and expressed as nmol of p-Np/min/cell. Results 
are reported as mean ± standard deviation.  
3.2.12 Mineralization Assay 
Mineralization of the extracellular matrix was measured using a quantichrom calcium 
detection kit (Bioassay Systems, CA, USA). Briefly, the samples were homogenized and 
digested in 0.5 N HCL overnight at room temperature. The calcium standards were 
prepared at various concentrations. Samples and working solution was mixed and 
incubated for 3 minutes. The absorbance was read at 570 nm with a microplate 
spectrophotometer (Emax, Molecular Devices). Results are reported as mean ± standard 
deviation.  
3.2.13 Tissue Mechanical Properties 
Biomechanical analysis was performed using Cartigen 9X bioreactor system. Using data 




calculated as the peak-to-peak stress divided by peak-to-peak strain on days 1, 14 and day 
28. Results are reported as mean ± standard deviation.  
3.2.14 Gene Expression 
The samples for gene expression were collected at Days 14 and 28. At each time point, 
scaffolds (n = five) were pooled, rinsed in PBS and homogenized in 500 µL lysis buffer 
(Qiagen, USA) and stored at -80oC until further processing. The RNA concentration and 
integrity was performed using a nanodrop and spectrophotometric analysis was 
performed to test the integrity of RNA. Cell lysate was centrifuged through a 
QIAshredder homogenizer column and combined with an equal volume of 70% ethanol. 
RNA was isolated using RNeasy Mini Kit (Qiagen) using manufacturer’s protocol. 
Quantitative reverse transcriptase (qRT) polymerase chain reaction (qRT-PCR) was 
performed using One Step QuantiTect SYBR Green RT-PCR Kit (Qiagen, USA) with 
Real-Time PCR instrument (Stratagene, MX4000, USA), according to manufacturer’s 
instructions. Briefly, the reverse transcription step ran for 30 min at 50oC, followed by a 
PCR initial activation step for 15 min at 95oC. Forty amplification cycles were 
performed, consisting of cDNA denaturation for 15 s at 94oC, annealing for 30 s at 55oC, 
and extension for 30 s at 72oC. QuantiTect Assay primers (Qiagen, USA) were used for 
analyzing chondrogenic differentiation by assessing SOX9, aggrecan, collagen types I, II, 
IX and X and chondroadherin gene expression. For osteogenesis differentiation, collagen 
type I, RUNX2, alkaline phosphatase, osteocalcin and osteopontin were analyzed. 
Samples were assayed in triplicates and the values were first normalized to the 




Fold change was determined by normalizing dynamic groups to perfusion only groups 
using 2^-ΔΔCT [94].  
3.2.15 Immunofluorescence Staining for Confocal Imaging 
The harvested samples were washed with PBS and fixed in 4% paraformaldehyde 
overnight at 4oC. The samples were then permeablized with 0.1% triton-x100 for 15 
minutes at room temperature. As a negative control, scaffolds without cells were 
immunostained along with harvested samples to ensure lack of any non-specific staining. 
A blocking serum consisting of 5% donkey serum or rabbit serum in 1% bovine serum 
albumin (BSA) was used to treat samples for 1 hour at room temperature to avoid 
nonspecific antibody binding. For cartilage tissue, the samples were incubated in 1:1000 
mouse antihuman collagen type II antibody in 1% BSA overnight at 4oC For bone tissue, 
the samples were incubated in 1:1000 rabbit antihuman collagen type I or rabbit 
antihuman osteocalcin antibody in 1% BSA overnight at 4oC. After a series of PBS 
washes, the samples were then incubated in 1:200 secondary antibody (donkey antimouse 
IgG or rabbit antigoat IgG in1% BSA, Invitrogen) along with 1:100 rhodamine phalloidin 
(Invitrogen) to view actin for 1 hour at room temperature. The nucleus was stained with 
4',6-diamidino-2-phenylindole (DAPI; Invitrogen). 
3.2.16 Statistical Analysis 
SPSS 20.0 software (SPSS Inc., IL, USA) was used for statistical analysis of all 
quantitative data. Results are expressed as mean ± standard deviation. The results were 
initially tested for normality (Shapiro Wilk test) and Levene’s equal variance test. Two-




Tukey’s tests were applied.  Probability (p) values < 0.05 were considered statistically 
significant.  
3.3 Results 
3.3.1 Day 0 Cell Attachment 
 
Figure 3.1 Confocal images of cells attached to scaffolds on day 0. Cultures stained for 













Figure 3.2 The number of cells attached to as-spun PVDF-TrFE, annealed PVDF-TrFE 
and PCL scaffolds at day 0. 
 
The confocal images confirmed the attachment of cells to all scaffolds as evidenced by 
intense F-actin and nucleus staining in Figure 3.1. Additionally there was no significant 
difference in number of cells attached to scaffold between all the three groups as shown 
in Figure 3.2. 
3.3.2 In vitro Chondrogenesis  
The piezoelectric scaffolds, as-spun and annealed PVDF-TrFE, were evaluated for their 
ability to support and enhance chondrogenesis of human MSCs as well as compare to 
non-piezoelectric, PCL, as a control.  MSCs were distributed throughout the fibrous 
constructs, which were cultured in chondrogenic induction medium over a period of 28 
days. After 28 days culture, all the constructs transitioned from loose fibrous material to 
an elastic like, discrete mass of tissue with a shiny appearance similar to hyaline cartilage 
as shown in Figure 3.3. To isolate the effects of dynamic compression stimulus on MSCs 
differentiation, all the quantitative results presented were normalized to perfusion group 
for each scaffold group. The actual values from quantitative results for chondrogenic 



















Figure 3.3 Cartilage tissue constructs at day 28 which underwent dynamic compression 
harvested from bioreactor. Scale bar = 6 mm. 
 
The cell proliferation was monitored by quantifying the DNA content of the 
scaffolds at days 14 and 28. For all the three groups, cell proliferation was significantly 
influenced by culture time as shown in Figure 3.4a. Dynamic stimulus encouraged 
increased cell proliferation at day 14 for both as-spun and annealed PVDF-TrFE when 
compared to perfusion group baseline. In contrast, for PCL scaffolds’ undergoing 
dynamic stimulus, number of cells decreased by 30% at day 14 when compared to 
perfusion group baseline. By day 28, cell number significantly decreased on as-spun and 
annealed PVDF-TrFE groups by 36% and 44% fold, respectively. Interestingly, annealed 
PVDF-TrFE scaffold groups demonstrated a higher number of cells at days 14 and 28 
when compared to as-spun PVDF-TrFE and PCL groups.  
To determine whether the piezoelectric scaffolds enhanced chondrogenesis, 
sulfated GAGs, collagen types II and I contents for each scaffold group was examined. 
The amount of GAGs, an indicator of hyaline cartilage proteoglycan, depended on culture 







PVDF-TrFE produced more total GAGs content compared with cells within as-spun 
PVDF-TrFE or PCL. By day 28, however, all three groups had significantly different 
amounts of total GAGs where as-spun PVDF-TrFE group had the highest GAGs amount. 
Interestingly, by day 28, all dynamic groups were well below the perfusion groups’ 
baseline indicating the increased GAGs production in perfusion groups than dynamic.  
Collagen type II, a mature hyaline cartilage marker, and collagen type I, marker 
for immature cartilage, production was quantified on all three constructs at days 14 and 
28. As-spun PVDF-TrFE scaffolds promoted an increased collagen type II production 
compared to PCL and annealed PVDF-TrFE constructs as shown in Figure 3.4c. 
Especially, by day 28, both as-spun and annealed PVDF-TrFE constructs demonstrated 
significantly higher collagen type II than PCL scaffolds. Collagen type II production 
remained unchanged over time for PCL constructs. Enhanced production of collagen type 
II production in both the piezoelectric, as-spun and annealed PVDF-TrFE can be 
attributed to dynamic compression stimulus compared to perfusion alone. Collagen type I 
synthesis was consistently lower in all scaffolds undergoing dynamic compression than 
perfusion groups. Nevertheless, collagen type I was detected in all three scaffolds and 
was significantly different between days 14 and 28 for all three constructs as shown in 
Figure 3.4d. Annealed PVDF-TrFE scaffolds consistently demonstrated the highest 
collagen type I production compared to as-spun PVDF-TrFE and PCL scaffolds. 
Collagen type I production increased on as-spun PVDF-TrFE and PCL groups and was 
statistically different.  
The quality of hyaline cartilage produced is assessed by noting the ratio of 




differences between days 14 and 28 where the ratio decreased with time. At day 14, PCL 
and as-spun PVDF-TrFE had the highest collagen types II/I ratio than annealed PVDF-
TrFE group. Interestingly, by day 28 as-spun PVDF-TrFE continued to demonstrate 







Figure 3.4 Biochemical analysis for MSCs chondrogenesis on PCL, as-spun PVDF-TrFE 
and annealed PVDF-TrFE scaffolds. Plots show cell number (a), total GAGs production 
(b), collagen type II production (c), collagen type I production (d) when normalized to 
perfusion only groups and collagen types II/I ratio (e) at days 14 and 28. At specific time 
point, significant difference between groups is noted by ^ p<0.05. Within a specific 
group, significant difference between time points is noted by # p<0.05. When all three 










































































































































































































   * 
 # 
#





Cartilage tissue specific gene expression was evaluated to assess MSCs 
differentiation on all scaffolds as shown in Figure 3.5. SOX9, an early chondrogenic 
transcription factor, was significantly different for all three groups at day 14. The PCL 
group had the highest expression at both days 14 and 28 when compared to as-spun and 
annealed PVDF-TrFE groups. SOX9 expression on annealed PVDF-TrFE significantly 
decreased by day 28. Aggrecan, proteoglycan of hyaline cartilage marker, was 
significantly up-regulated on PCL scaffolds compared to as-spun and annealed PVDF-
TrFE scaffolds at day 14. Aggrecan expression over time remained constant on all 
groups.  At day 28, aggrecan expression was significantly different between PCL and as-
spun PVDF-TrFE groups. Collagen type II expression was significantly up-regulated on 
annealed PVDF-TrFE group when compared to other groups. Collagen type IX, known to 
interact with collagen type II and found in hyaline cartilage, was significantly higher for 
as-spun PVDF-TrFE group at day 14 than PCL and annealed PVDF-TrFE groups. 
Collagen type IX expression down-regulated over time on as-spun PVDF-TrFE, but was 
up-regulated on annealed PVDF-TrFE constructs. There was no change in gene 
expression levels for PCL over time. Chondroadherin, another mature hyaline cartilage 
marker, expression was significantly up-regulated on annealed PVDF-TrFE group 
compared to PCL and as-spun PVDF-TrFE at day 14. Between time points, PCL and 
annealed PVDF-TrFE had significant increase in chondroadherin expression. Collagen 
type I expression on as-spun PVDF-TrFE constructs significantly decreased by day 28. 
However, collagen type I expression significantly increased on annealed PVDF-TrFE 




hypertrophic marker, was significantly up-regulated annealed PVDF-TrFE scaffolds by 





Figure 3.5 Chondrogenic gene expression for SOX9 (a), aggrecan (b), collagen type II 
(c), collagen type IX (d), chondroadherin (e), collagen type I (f) and collagen type X (h) 
for MSCs cultured on as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL scaffolds at 
days 14 and 28. At specific time point, significant difference between groups is noted by 
^ p<0.05. Within a specific group, significant difference between time points is noted by 
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Dynamic modulus of all three groups increased over time as shown in Table 3.1. 
PCL and annealed PVDF-TrFE groups had statistically different dynamic modulus 
between days 1, 14 and 28. As-spun PVDF-TrFE construct’s dynamic modulus 
significantly increased since day 1 but remain unchanged between day 14 and 28. At day 
1, all groups had statistically different dynamic modulus where annealed PVDF-TrFE 
demonstrated higher modulus. By day 28 PCL group had significantly higher dynamic 
modulus than both of the PVDF-TrFE groups.  
Table 3.1 Dynamic Young’s Modulus of Cartilage Tissue Constructs, which underwent 
dynamic compression 
 As-spun PVDF-TrFE (kPa) Annealed PVDF-TrFE (kPa) PCL (kPa) 
Day 1 31.1 ± 2.9a, # 55.2 ± 0.73b,# 18.9 ± 0.7b,# 
Day 14 77.4 ± 18.9 102.4 ± 1.1b,* 97.6 ± 1.1b,* 
Day 28 73.8 ± 3.9# 82.5 ± 0.75b, # 89.3 ± 1.0b, # 
a p<0.05 significant difference between Day 1 and other time points of that group. 
b p<0.05 significant difference between all time points of that group. 
# p<0.05 significant difference between all groups at that time point. 
* p<0.05 significant difference between annealed PVDF-TrFE and PCL at day 14. 
 
The confocal images (Figures 3.6 – 3.8) confirmed cell attachment as evidenced 
by actin staining on all the scaffolds. As-spun PVDF-TrFE scaffold group showed intense 
staining for collagens types II & I and SOX9. Annealed PVDF-TrFE group had no 
detectable staining for SOX9 at days 14 and 28. Collagen type II was detectable only at 
day 28 and collagen type I was intensely stained on both days. On PCL scaffolds collagen 
type II and SOX9 was detected. Collagen type I staining was intensely stained at days 14 








Figure 3.6 As-spun PVDF-TrFE scaffolds confocal images showing tissue cross-section 
(scale bar = 500 µm) and distribution of collagen type II, SOX9 and collagen type I 
proteins within that cross section cultured in chondrogenic media, which underwent 
dynamic compression at days 14 and 28. Scaffolds without cells (control) and scaffolds 
with cultures stained for SOX9 (green), collagen type I (green), collagen type II (green), 
F-actin (red) and nucleus (blue). Scale bar = 50 µm.   
Tissue Cross-section 
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Figure 3.7 Annealed PVDF-TrFE scaffolds confocal images showing tissue cross-section 
(scale bar = 500 µm) and distribution of collagen type II, SOX9 and collagen type I 
proteins within that cross section cultured in chondrogenic media, which underwent 
dynamic compression at days 14 and 28. Scaffolds without cells (control) and scaffolds 
with cultures stained for SOX9 (green), collagen type I (green), collagen type II (green), 
F-actin (red) and nucleus (blue). Scale bar = 50 µm.   
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Figure 3.8 PCL scaffolds confocal images showing tissue cross-section (scale bar = 500 
µm) and distribution of collagen type II, SOX9 and collagen type I proteins within that 
cross section cultured in chondrogenic media, which underwent dynamic compression at 
days 14 and 28. Scaffolds without cells (control) and scaffolds with cultures stained for 
SOX9 (green), collagen type I (green), collagen type II (green), F-actin (red) and nucleus 
(blue). Scale bar = 50 µm.   
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3.3.3 In vitro Osteogenesis 
The osteogenic differentiation potential of MSCs was evaluated on the piezoelectric 
scaffolds, as-spun and annealed PVDF-TrFE, as well as compare to non-piezoelectric, 
PCL, as a control when placed in bioreactor where dynamic compression was applied 
with continuous perfusion and continuous perfusion only.  MSCs were cultured in 
osteogenic induction medium over a period of 28 days. After 28 days culture, all the 
constructs transitioned from loose fibrous material to slightly firm, discrete mass of tissue 
as shown in Figure 3.9. To demonstrate the effects of dynamic compression stimulus on 
MSCs differentiation, all the quantitative results presented were normalized to perfusion 
group for each scaffold group are represented as fold change mean standard deviation. 
The actual values from quantitative results for chondrogenic bioreactor studies are shown 
in Appendix B.  
 
Figure 3.9 Tissue constructs in osteogenic media, which underwent dynamic 











Figure 3.10 Biochemical analysis for MSCs osteogenesis on PCL, as-spun PVDF-TrFE 
and annealed PVDF-TrFE scaffolds. Plots show cell number (a), total alkaline 
phosphatase activity (b), mineralization (c) and osteocalcin (d) where dynamic group is 
normalized to perfusion only group at days 14 and 28. At specific time point, significant 
difference between groups is noted by ^ p<0.05. Within a specific group, significant 
difference between time points is noted by # p<0.05. When all three groups are 
significantly different is noted by * p<0.05. 
 
The cell number in dynamic groups was higher than in perfusion only groups for 
all three scaffolds as shown in Figure 3.10a. There were no significant differences noted 
between scaffold groups and over time. To determine whether piezoelectric scaffolds 
enhanced osteogenesis, alkaline phosphatase (ALP), mineralization, and osteocalcin 
content in each group was examined and is shown in Figure 3.10b-d. ALP activity was 
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annealed PVDF-TrFE and PCL groups. ALP activity on both annealed PVDF-TrFE and 
PCL was significantly higher by almost five-fold and two-fold at days 14 and 28, 
respectively, than as-spun PVDF-TrFE, and there were no statistical differences noted 
between annealed PVDF-TrFE and PCL. 
Mineralization was quantified by assaying the calcium concentration in each 
group. Dynamic compression stimulus enhanced mineralization on annealed PVDF-TrFE 
and PCL but only slightly on as-spun PVDF-TrFE. At day 14, PCL group was 
significantly higher than as-spun PVDF-TrFE group. No differences were detected 
between annealed PVDF-TrFE group , as-spun PVDF-TrFE and PCL groups. By day 28, 
mineralization increased significantly on annealed PVDF-TrFE compared to other 
groups. Osteocalcin, a protein produced from mature bone cells, was significantly higher 
on PCL scaffolds at day 14 compared to both as-spun and annealed PVDF-TrFE groups. 
At day 28, annealed PVDF-TrFE had higher osteocalcin production but was not 
statistically different from other groups.  
Gene expression (Figure 3.11) characteristic for bone formation and maturation 
was predominantly expressed for annealed PVDF-TrFE scaffold groups. ALP and 
RUNX2, early osteogenic markers, was significantly up regulated on annealed PVDF-
TrFE group compared to as-spun PVDF-TrFE and PCL scaffold groups at day 28. 
Collagen type I expression was down regulated in all dynamic groups compared to 
perfusion groups. At day 14, collagen type I was significantly lower on annealed PVDF-
TrFE scaffolds. Osteopontin, a mature bone marker, expression was highest on PCL 
scaffolds at day 14. However, by day 28, annealed PVDF-TrFE groups had significantly 




was no change in osteopontin expression on as-spun PVDF-TrFE over time. Osteocalcin 
expression was significantly higher on annealed PVDF-TrFE at day 28.  





Figure 3.11 Gene expression analysis for MSCs osteogenesis on PCL, as-spun PVDF-
TrFE and annealed PVDF-TrFE scaffolds. Plots show alkaline phosphatase (a), Runx2 
(b), collagen type I (c), osteopontin (d) and osteocalcin (e) where dynamic group is 
normalized to perfusion only group at days 14 and 28. At specific time point, significant 
difference between groups is noted by ^ p<0.05. Within a specific group, significant 
difference between time points is noted by # p<0.05. When all three groups are 
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Confocal images were taken at different areas of the tissue cross-section to 
compare collagen type I and osteocalcin detection between all groups at day 28 as shown 
in Figures 3.12 - 3.14. The cell attachment was confirmed by intense actin cytoskeleton 
staining on all scaffolds. As-spun PVDF-TrFE scaffolds stained for both collagen type I 
and osteocalcin in all the three areas. The center section had sparse staining for both 
collagen type I and osteocalcin.  Annealed PVDF-TrFE scaffolds, however, demonstrated 
intense staining for collagen type I and osteocalcin on all the sections. PCL scaffolds had 
intense staining collagen type I and osteocalcin on the edge and top sections of the 
construct. However, in center section, there was not much detectable staining for both 
proteins.  
Dynamic Young’s modulus of all three groups increased over time as shown in 
Table 3.1. Annealed PVDF-TrFE groups had significantly different dynamic modulus 
between days 1, 14 and 28. As-spun PVDF-TrFE construct’s dynamic modulus 
significantly increased since day 1 but remain unchanged between day 14 and 28. PCL 
group’s dynamic modulus significantly increased by day 28. At day 14, as-spun PVDF-
TrFE had the highest modulus than other groups. By day 28 as-spun PVDF-TrFE and 
PCL group had significantly higher dynamic modulus than annealed PVDF-TrFE groups.  
 
Table 3.2 Dynamic Young’s Modulus of Bone Tissue Constructs, which underwent 
Dynamic Compression 
 As-spun PVDF-TrFE (kPa) Annealed PVDF-TrFE (kPa) PCL (kPa) 
Day 1 50.7 ± 4.8a 57.3 ± 6.5b 76.4 ± 7.7 
Day 14 145.7 ± 2.5# 130.4 ± 5.9b,# 88.1 ± 24.2#  
Day 28 156.1 ± 16.1  109.0 ± 11.6b, * 210 ± 61.8c 
a p<0.05 significant difference between Day 1 and other time points of that group. 
b p<0.05 significant difference between all time points of that group. 
c p<0.05 significant difference between day 28 and other time points of that group. 
# p<0.05 significant difference between all groups at that time point. 





Figure 3.12 As-spun PVDF-TrFE scaffolds confocal images showing tissue cross-section 
(scale bar = 500 µm) and distribution of collagen type I and osteocalcin proteins within 
that cross section cultured in osteogenic media, which underwent dynamic compression 
at day 28. Scaffolds without cells (control) and scaffolds with cultures stained for 
collagen type I (green), osteocalcin (green), F-actin (red) and nucleus (blue). Scale bar = 


























Figure 3.13 Annealed PVDF-TrFE scaffolds confocal images showing tissue cross-
section (scale bar = 500 µm) and distribution of collagen type I and osteocalcin proteins 
within that cross section cultured in osteogenic media, which underwent dynamic 
compression at day 28. Scaffolds without cells (control) and scaffolds with cultures 
stained for collagen type I (green), osteocalcin (green), F-actin (red) and nucleus (blue). 
Scale bar = 50 µm.   
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Figure 3.14 PCL scaffolds confocal images showing tissue cross-section (scale bar = 500 
µm) and distribution of collagen type I and osteocalcin proteins within that cross section 
cultured in osteogenic media, which underwent dynamic compression at day 28. 
Scaffolds without cells (control) and scaffolds with cultures stained for collagen type I 
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3.4 Discussion  
The goal of the bioreactor studies was to apply physiologically relevant mechanical 
stimulus to piezoelectric scaffolds and assess its effects on MSCs differentiation towards 
chondrogenesis and osteogenesis in vitro. In these studies, PCL served as a non-
piezoelectric scaffold. It was hypothesized that piezoelectric scaffolds will enhance 
chondrogenesis and osteogenesis. The results confirmed an increased chondrogenic 
differentiation of MSCs on as-spun PVDF-TrFE scaffolds as determined from GAG, 
collagen type II and gene expression compared to PCL group. Additionally, annealed 
PVDF-TrFE scaffolds demonstrated an enhanced MSCs mineralization and gene 
expression in osteogenic cultures compared to PCL group. To our knowledge, the present 
work is the first report using a compression perfusion bioreactor system for stimulating 
piezoelectric materials.   
In the chondrogenic study, as-spun PVDF-TrFE constructs favored 
chondrogenesis compared to other groups. This finding was supported by an increase in 
the collagen type II protein production that overlapped with increased collagen type IX 
gene expression, a characteristic of mature chondrocytes. Collagen IX is located at the 
surface of heterotypic collagen type II/XI fibrils and influences the assembly of these 
collagens. Lack of Collagen IX has been shown to result in degenerative joint lesions in 
mice further emphasizing its importance in stabilizing cartilage matrix [95]. During early 
development, MSCs condense into aggregates transforming into prechondroblasts. 
Within this precartilage stage, heterogeneous population of cells exists where different 
maturation stages of MSCs determine the production of stem cell, chondrogenic or 




differentiation occurs, a switch from collagen type I to type II occurs [84]. This was 
observed on as-spun PVDF-TrFE constructs where collagen type I gene expression 
decreased over time. However, collagen type I protein was detected and was shown to 
increase slightly by day 28 indicating the presence of undifferentiated MSCs. 
Furthermore, SOX9 and collagen type II gene expression was found to be lower on as-
spun PVDF-TrFE indicating a heterogeneous population of undifferentiated MSCs along 
with a subset population of mature chondrocyte like phenotype within the construct. The 
confocal images, however, does confirm the presence of SOX9 by intense staining and 
collagen type II protein production did increase over time in constructs. Interestingly, 
collagen type X expression was consistently lower on as-spun PVDF-TrFE group, 
indicating the maturation of MSCs into mature chondrocytes while maintaining it in pre-
hypertrophic stage. Barry et al. have shown that undifferentiated MSCs do express 
collagen type X mRNA early in cultures that gets down regulated as MSCs differentiates 
into chondrocytes [84]. Annealed PVDF-TrFE scaffolds had increased cell proliferation 
and did not demonstrate increased production of hyaline cartilage markers. Instead, 
hypertrophic gene expression of collagen types X and I protein was enhanced, indicating 
MSCs hypertrophy and fibrocartilage tissue formation. 
In bone studies, up-regulation of bone transcription factor, Runx2 in association 
with other bone markers ALP, osteocalcin and osteopontin provided evidence of 
increased MSCs differentiation towards osteogenesis especially in dynamic compression 
group. The application of cyclic compression with or without perfusion has been 
identified as a positive effect on MSCs differentiation to osteoblasts [96]. In the current 




well as dynamic compression groups. MSCs during osteogenic differentiation undergo 
stepwise maturational stages. At early stage, MSCs begin to express Runx2, which also 
controls the later expression of ALP and mature bone marker, osteopontin. In this study, 
cells on annealed PVDF-TrFE scaffolds did demonstrate highest Runx2 expression, 
which also overlapped with increased expression ALP, osteopontin, and osteocalcin gene 
expression. This was further supported by protein results for ALP and osteocalcin 
production at later time point.  PCL scaffolds may have consisted of a heterogeneous 
population of MSCs as evidenced in large standard deviations noted in protein results but 
also lower gene expression of mature bone markers. The enhanced osteoblasts markers 
were not evident on as-spun PVDF-TrFE and PCL groups indicating that there may be an 
influence of inherent piezoelectric properties of annealed PVDF-TrFE in combination 
with dynamic stimulus influencing this maturation. From chondrogenic studies, annealed 
PVDF-TrFE favored hypertrophy, which may be the reason for observing enhanced 
MSCs osteogenesis in the bone studies.  
In the present study, dynamic moduli for both piezoelectric and PCL scaffolds 
were lower than natural cartilage dynamic modulus [97]. These findings were similar to 
previously published studies using PCL [47, 98] and the most commonly used agarose 
gels for cartilage and bone tissue engineering [99]. Possible explanation for this 
difference, include the heterogeneous production of GAGs and collagen type II protein 
within all the constructs which was primarily restricted to the ~0.5 mm in depth from the 
edge of the scaffold as confirmed in confocal images. A previous study has shown an 
increase in mechanical properties by delaying the application of dynamic compression on 




from day 1 after cell seeding. This could have resulted in reduced cell attachment over 
time and variable differentiation of MSCS resulting in heterogeneous production of 
proteins, which contribute to the mechanical properties of in vitro tissue.  
PCL, in this study, served as a non-piezoelectric control. Though PCL has a 
different surface chemistry from PVDF-TrFE, PCL was chosen primarily due to its slow 
degradation rate and ability to fabricate fibers similar in morphology and size to PVDF-
TrFE scaffolds. Additionally, its well known for its biocompatibility with many cell types 
and also has been FDA approved for medical applications such as wound dressings, 
sutures and stents. PCL chondrogenic gene expression of collagen types II and I, 
presented in this study, was comparable to a previously published study where similar 
trends of gene expression were noted on micron sized PCL fibers [101]. Multiple studies 
have indicated MSCs seeded on PCL scaffolds for chondrogenesis have shown to become 
hypertrophic phenotype in long cultures times [98, 101]. In this study, however, increased 
collagen type X expression was not as evident as increased collagen type I, with no 
change in collagen type II production. The tissue formed in PCL may be fibrocartilage as 
evidenced by increasing collagen type I production. On the other hand, PCL scaffolds 
have been shown to support MSCs osteogenesis but are often combined with 
hydroxyapatite and/or β-tricalcium phosphate to improve cell adhesion and mechanical 
strength [22, 58]. In this study, PCL did show higher osteocalcin production when 
compared to PVDF-TrFE scaffolds. Interestingly, mineralization and osteogenic gene 
expression was consistently higher on annealed PVDF-TrFE scaffolds. This may indicate 
an influence of localized piezoelectric activity between cell and fiber interface during its 




A previous study used electrospun polyurethane (PU) as a non-piezoelectric 
control when comparing with co-electrospun PU and PVDF for wound healing 
applications. The study confirmed the enhanced cell proliferation of fibroblasts and 
protein production due to the application of cyclic tension of PU/PVDF scaffolds [102]. 
PCL as the control was considered advantageous since direct comparisons can be made 
with a well-established polymer for bone and cartilage tissue engineering applications. 
The majority of the studies used PVDF films where it was feasible to fabricate 
piezoelectric β-phase PVDF and α-phase as a non-piezoelectric control. These studies 
have shown variable cell response of fibroblasts having better cell spreading on α-phase 
films than on β-phase films compared to non-piezoelectric films [103]. Ribeiro et al. 
demonstrated that poled β-phase PVDF films promoted higher osteoblast adhesion and 
proliferation, which was further enhanced under dynamic conditions when compared to 
non-poled PVDF films [104]. Osteogenic differentiation of human adipose derived stem 
(ASCs) cells was enhanced on pre-absorbed fibronectin on poled β-phase films compared 
to non-poled PVDF [105]. However, no study to date has shown MSCs differentiation on 
piezoelectric PVDF-TrFE scaffolds especially using a compression bioreactor for both 
chondrogenesis and osteogenesis making it difficult to directly compare our findings with 
others.  
In the current study, it is evident that even with similar polymer chemistries of as-
spun and annealed PVDF-TrFE, MSCs demonstrated different differentiation paths where 
as-spun PVDF-TrFE scaffolds enhanced chondrogenesis and annealed PVDF-TrFE 
scaffolds favored osteogenesis. It is speculated that this preferential differentiation choice 




compression of the piezoelectric scaffolds, which may be producing different levels of 
electrical fields in culture. This reflects the complexity of this study for understanding 
and isolating the impact of mechanical stimulus and electrical stimulus. Electrical field 
measurements within bioreactor environment were not made in this study due to 
limitations in the experimental design. A recent study, however, has confirmed electrical 
signal albeit a dampened output of ~ ± 0.1 V from aligned PVDF-TrFE scaffolds at 2 Hz 
when placed in cell culture media [106]. The reduction of electrical signal was attributed 
to conductivity and ionic components of cell culture media. Annealed PVDF-TrFE may 
be producing higher electrical output than as-spun PVDF-TrFE to which MSCs were 
sensitive.   
It has been well established that cells are able to respond to electrical stimulation 
by activation of calcium channels present within cell membranes and release of calcium 
from intracellular calcium repositories [107]. Extensive work by Brighton et al. have 
shown that electrical field causes an increase in extracellular calcium influx via voltage 
gated calcium channels and an increase in intracellular calcium levels can induce 
osteogenesis and chondrogenesis through a calcineurin/NF-AT (nuclear factor of 
activated T cells) signaling pathway [51, 52]. McCullen et al. have shown that ASCs 
exposed to alternating current electric field (AC; 1, 3 and 5 V/cm) at 1 Hz induced a dose 
dependent increase in calcium signaling during osteogenic differentiation. Their results 
showed that AC electric field of 1V/cm at 1 Hz showed a significant increase in the 
amount of mineralization produced relative to controls and higher electric fields [108]. 
Similar findings have been reported during MSCs osteogenesis where MSCS exposed to 




emphasize that varying electrical fields is directly proportional to the amount of calcium, 
which enter the cells through voltage gated calcium channels on its outer membrane. The 
cytoplasmic calcium concentrations have been shown to affect downstream signaling 
pathways and release of growth factors, which later impacts the differentiation of MSCs 
[110].  Fitzsimmons et al. showed that application of low amplitude (10-7 V/cm), low 
frequency (<100 Hz) capacitively coupled electric field led to an increase in insulin like 
growth factor (IGF-II) mRNA accumulation, IGF-II secretion and IGF-II receptors in an 
osteoblast. Other growth factors such as cyclic adenosine monophosphate (cAMP) and 
prostaglandin E2 were shown to be released following electrical stimulation [51]. Similar 
phenomenon may be occurring in as-spun and annealed PVDF-TrFE where variable 
MSCs response was shown as evidenced in the current study findings.  
Mechanical stimulation also impacts calcium signaling where, unlike electrical 
stimulus, calcium is released via intracellular repositories [51]. The main pathway 
involved is the activation of inositol phosphate cascade in the cell membrane. When a 
cell experiences mechanical strain, inositol phosphate increase resulting in release of 
intracellular calcium stores in endoplasmic reticulum [51]. The amount of calcium 
released has an effect on downstream signaling pathways. Brighton et al. have 
demonstrated that electrical stimulus and mechanical strain merge to the common 
pathway ultimately resulting in increase in activated cytoskeletal calmodulin.  
In conclusion, this study has demonstrated that piezoelectric scaffolds can 
enhance cartilage and bone tissue formation using a compression bioreactor system. 




setting in order to understand the induced electric field from piezoelectric scaffold and its 




  CHAPTER 4
DISCUSSION 
Piezoelectric, three-dimensional, fibrous PVDF-TrFE scaffolds are intriguing for 
osteochondral tissue engineering applications due its inherent ability to produce electrical 
fields when subjected to cyclic compression. Endogenous electrical fields existence has 
been well acknowledged during embryonic development, wound healing and limb 
regeneration. During wound healing, for instance, steady electrical fields ranging 
between 1 and 2 V/cm have been estimated at the surface of wounds that exists locally 
for days after the injury [1]. Illingworth et al. have also reported the measurements of 
electrical currents of 30 A/cm2 during the regeneration process of amputated fingertips in 
children, which were comparable to limbs regeneration in salamander [2]. Streaming 
potentials and piezoelectricity of collagen molecules has been shown to contribute to 
electrical behavior of bone [1, 3]. Similarly, chondrocytes within cartilage have been 
shown to respond to multiple biophysical cues such as mechanical signal from joint 
loading and streaming potentials caused by the flow of interstitial fluid over the 
negatively charged GAGs in its extracellular matrix [4]. Therefore, the application of 
piezoelectric PVDF-TrFE scaffolds provides a unique method for investigating 
mechanisms involved in MSCs differentiation to electrical fields generated when 
dynamically compressed within a bioreactor system for osteochondral tissue repair.  
The results of this study demonstrated the piezoelectric properties of PVDF-TrFE 
scaffolds. Annealing PVDF-TrFE increased the piezoelectric β-phase in scaffolds and 
also impacted the electrical output when subjected to compressive deformations. 




TrFE scaffolds and osteogenesis was promoted on annealed PVDF-TrFE scaffolds when 
stimulated in compression bioreactor compared to PCL control. The differences in 
electrical output from as-spun and annealed PVDF-TrFE scaffolds and combined with 
dynamic compression could be driving MSCs differentiation to either chondrogenic or 
osteogenic lineages. This is the first time to our knowledge, that fibrous, PVDF-TrFE 
scaffolds have been investigated for bone and cartilage tissue engineering applications.  
Annealing is commonly used with PVDF and PVDF-TrFE films to enhance 
degree of crystallinity, which directly influences the electrical behavior of PVDF-TrFE. 
Previous work with PVDF-TrFE films has suggested that choosing annealing temperature 
above Tc but below Tm increases the grain size and crystallinity of orientation of β-phase 
while polymer chains align parallel to the film substrate with polarization dipole moment 
perpendicular to the substrate [5, 6]. In this study, the annealing temperature (135oC) was 
between Curie (Tc = 113oC) and melting temperatures (Tm = 147.4oC) of electrospun as-
spun PVDF-TrFE scaffolds, which resulted in increased crystallinity and β-phase fraction 
in annealed electrospun PVDF-TrFE scaffolds. More importantly, annealed PVDF-TrFE 
scaffolds demonstrated an increase in voltage output from applying physiologically 
relevant compression deformation compared to as-spun PVDF-TrFE. Electric field 
generated by piezoelectric scaffolds was approximated from force sensors results where 
as-spun PVDF-TrFE had ~112.5 mV/cm and annealed PVDF-TrFE generated ~ 5.8 V/cm 
electric fields when subjected to 10% strain at 1 Hz in dry conditions. PCL scaffolds did 
not generate voltage output under similar dynamic deformations. The forces sensor 
findings from this study are comparable with a previous study, where pressure sensor 




voltage of about 400 mV when subjected to 0.2 MPa compressive stress at 5.3Hz [7]. 
Nevertheless, aligned electrospun fibers can result in higher voltage outputs, which may 
be due to the arrangement of fibers. Persano et al. fabricated pressure sensor from aligned 
PVDF-TrFE fibers and demonstrated output ranging from 0.79 – 1.3 V under 0.1-1 Pa at 
1 and 2 Hz [8]. Electrical properties of PVDF-TrFE have been shown to depend on 
PVDF to TrFE ratio, solvent choice, polymer concentration and orientation of 
electrospun PVDF-TrFE fibers. These parameters affect the morphology, fiber diameters 
and affect the dipole moment orientation and size of the β-phase crystal within these 
fibers.  
Overall, the chondrogenic bioreactor studies reinforced the importance of 
dynamic compression for MSCs differentiation towards chondrogenesis by increasing 
mature hyaline cartilage marker, collagen type II production especially on piezoelectric 
scaffolds. Of the piezoelectric groups compared, as-spun PVDF-TrFE enhanced 
chondrogenesis of MSCs as demonstrated by an increased production of collagen type II 
that overlapped with increased collagen type IX gene expression and demonstrated the 
highest collagen type II/I ratio later in culture. Previous studies have applied electrical 
stimulus using direct current or capacitively coupled modes to cultures of MSCs and 
chondrocytes seeded on tissue culture plates or suspended in agarose constructs. Nogomi 
et al. applied 5 µA direct current stimulation to differentiate muscle derived MSCs into 
chondrocytes instead it was demonstrated that differentiated chondrocytes had enhanced 
proliferation and cartilage formation at the cathode region with no effect on MSCs [9].  
Brighton et al. demonstrated that electrical stimulus to bovine articular chondrocytes up-




chondrocytes seeded agarose gel samples were stimulated by the application of sinusoidal 
current density, which enhanced chondrocyte proliferation and collagen and GAGs 
production [11]. In this study, only annealed PVDF-TrFE scaffolds demonstrated 
increased cell proliferation but the expression of hyaline cartilage markers was not 
enhanced compared to as-spun PVDF-TrFE. In the electrical stimulus studies, the 
duration of the electrical stimulus varied from 30 minutes to 7 days in culture and was 
predominantly performed with chondrocytes therefore limiting the comparison with the 
current study.  To date in cartilage tissue engineering, there has been some success in 
combining agarose-based scaffolds with chondrocytes to engineer cartilage with 
properties approximating those of native tissue. For instance, Hu et al. demonstrated self-
assembled cartilage tissue formation when chondrocytes were seeded on agarose 
substratum, and this tissue-engineered cartilage contained two thirds more GAG/dry 
weight than native cartilage. Collagen/dry weight was one-third the level of native tissue 
and the mechanical stiffness reached more than one third that of native tissue [12]. 
Nevertheless, replicating native tissue properties remains a challenge.   
In all the scaffolds groups, collagen types X and I was detected through gene 
expression. These results indicate the presence of heterogeneous populations within the 
constructs, which is a well-acknowledged limitation of MSCs as a cell source for 
cartilage repair. Murdoch et al. analyzed cartilage tissue formation from individual clonal 
populations of MSCs, and demonstrated variable differentiation capacity of individual 
clones [13].  Pelttari et al. compared cartilage formation potential for human MSCs and 
chondrocytes cultured as pellets and the study demonstrated that in MSCs pellets, 




well before collagen type II was expressed [14].  Following this, broad range of hyaline 
cartilage markers together with markers for terminal differentiation and osteoblast was 
detected. In contrast, hypertrophy and terminal differentiation related genes were not 
detectable in chondrocyte pellets when subjected to similar chondrogenic culture 
conditions as MSCs [14]. This was indicative of MSCs undergoing endochondral 
ossification path with ultimately forming bone like tissue. Interestingly, in our study, as-
spun PVDF-TrFE scaffolds showed down regulation of collagen type I and maintained 
lower expression of collagen type X compared to annealed PVDF-TrFE, suggesting that 
material properties combined with dynamic compression maybe influencing MSCs 
phenotype and reduced expression of hypertrophic marker. This was a promising finding 
since to date curbing MSCs differentiation towards hypertrophy has not been well 
controlled in scaffolds based cartilage repair in vitro cultures.  
Application of dynamic compression enhanced MSCs osteogenic differentiation 
on piezoelectric annealed PVDF-TrFE scaffolds compared to PCL group and annealed 
PVDF-TrFE perfusion group. Our findings were comparable to Jagodzinski et al. study 
where MSCs seeded on demineralized bovine bone scaffolds enhanced mature bone 
marker, osteocalcin, production when subjected to 10% compressive strain with perfusion 
for three weeks when compared to perfusion only groups [15]. Piezoelectric films of 
PVDF and PVDF-TrFE films have been investigated for bone tissue engineering. 
Dynamically stimulated piezoelectric β-PVDF films demonstrated increased proliferation 
and differentiation of human adipose stem cells compared to static conditions and non-
piezoelectric PVDF films when cultured under similar conditions of piezoelectric β-




tissue engineering [16]. An advantage of using films is the feasibility of fabricating a 
non-piezoelectric control with same chemistry as the piezoelectric group. However, films 
lack the necessary 3D structure to facilitate tissue ingrowth and formation of organized 
tissue further limiting its clinical relevancy. For instance, PVDF-TrFE/barium titanate 
composite was shown to support in vivo bone formation and expression marker of mature 
bone when implanted in rat calvarial bone defects, but there was no tissue in growth 
within the composite and layer of fibrous tissue was formed at the composite interface 
[17]. Long-term use of such films for tissue repair is questionable. Nevertheless, MSCs 
were shown to respond favorably to annealed PVDF-TrFE scaffolds and demonstrating 
its osteoinductive properties for its osteogenic differentiation. 
The current study did not measure electrical potentials within bioreactor cultures 
during tissue formation. However, we have been able to make some electrical 
measurements from annealed PVDF-TrFE (0.8 mV) scaffolds subjected to 40% strain at 
1 Hz when placed in the phosphate buffered saline (PBS) bath. A recent study, has also 
confirmed the electrical signal albeit a dampened output of ~ ± 0.1 V from aligned 
PVDF-TrFE scaffolds at 2 Hz when placed in cell culture media [18]. We hypothesize 
that as-spun PVDF-TrFE will have lower electrical output due to aforementioned 
material properties and has lower approximated electric field of 112.5 mV/cm when 
compared to annealed PVDF-TrFE, which has an approximated electric field of 5.8 V. 
The differences in electrical output from as-spun and annealed PVDF-TrFE scaffolds 
combined with dynamic compression could be the driving factors for MSCs 
differentiation to either chondrogenic or osteogenic lineages on both the piezoelectric 
scaffolds. We are currently in process of optimizing the method for obtaining voltage 
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outputs within the bioreactor system, and this method will enable making measurements 
from tissue construct during culture period.  
Previous electrical stimulus studies have repeatedly shown that MSCs respond to 
electrical stimulation by activation of calcium channels present within cell membranes 
[19]. Extensive studies by Cho et al. have established that varying electrical fields is 
directly proportional to the amount of calcium, which enter the cells through voltage 
gated calcium channels on its outer membrane [20]. The cytoplasmic calcium 
concentrations have been shown to affect downstream signaling pathways and release of 
growth factors, which later impacts the differentiation of MSCs towards chondrogenesis 
and osteogenesis [20-22].  As a future work, it will be important to investigate the 
calcium level changes within MSCs when as-spun and annealed PVDF-TrFE scaffolds 
are subjected to dynamic compression. This finding will be essential to explain the 
signaling pathways involved and allow us to compare to previously reported electrical 
stimulus studies.  
In osteochondral tissue engineering, it has been suggested that scaffolds should be 
porous with at least 300 µm pore size and mechanically similar to native tissue in order to 
support tissue in growth and sustain joint loading [23]. Electrospun scaffolds offer large 
surface area relative to volume and nano to micron range fibers, which has been shown to 
be beneficial for MSCs based cartilage bone growth in vitro [24]. In our study, PVDF-
TrFE scaffolds had an average inter-fiber spacing <200 µm. The confocal images 
confirmed cell infiltration, but majority of the extracellular matrix production was 
restricted to the periphery around the scaffold. This could be due to limited oxygen and 
nutrient transport throughout the scaffolds. The bioreactor also uses perfusion as a 
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mechanism for the transport of media throughout the scaffold in an unconfined space. So 
the fluid may not have entered the scaffold and may have flowed around the scaffold as 
the tissue developed, which could have limited the efficient transport of nutrients and 
oxygen in the center of the scaffold.  
One of the limitations in our study was that the mechanical properties of all the 
three scaffold groups were found to be much lower when compared to native cartilage 
and bone. In our study, cell density was 1 million cells/mL, which is lower than the 
previously reported studies where cell density varied between 10 – 60 million cells/mL 
[25-27]. This could have contributed to the lower mechanical properties observed as 
compared to previous studies. For instance, Mauck et al. demonstrated that higher 
seeding cell density (60 million cells/mL) in agarose hydrogels showed >2 fold increase 
in mechanical properties relative to free swelling controls. In bone tissue engineering, 
scaffolds aim to mimic bone tissue properties where bone is a composite consisting of 
hydroxyapatite and collagen fibers, and for this reason, polymers are combined with 
ceramics to enhance mechanical properties, and have demonstrated success in bone 
regeneration. For instance, PCL/tricalcium phosphate (TCP) based composite 
demonstrated 3 times higher compressive modulus than PCL group, and human alveolar 
osteoblasts proliferation and expression of bone markers was enhanced [28]. Polymer 
based scaffolds such as clinically available PCL (Osteopore) constructs are extensively 
used for non-load bearing bone repair such as craniofacial applications [29]. However, 
the objective of our study was to evaluate the influence of piezoelectric materials on 
MSCs differentiation, and the addition of ceramics will further confound the effects of 
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scaffolds. Nevertheless, additions of ceramics to piezoelectric scaffolds may be a useful 
strategy when developing scaffolds for preclinical studies.  
Another limitation in our study is the lack of a non-piezoelectric scaffold with 
same chemistry as PVDF-TrFE scaffolds. We had attempted to prepare non-piezoelectric 
scaffold by coating electrospun PCL fibers with PVDF solution. However, PCL scaffolds 
became stiff with film like morphology; thus making it unusable for bioreactor studies.  
Annealing PVDF-TrFE films above Tm has been shown to retain its piezoelectric activity 
[6]. Therefore, limiting our attempts to prepare a non-piezoelectric scaffold with PVDF-
TrFE. Though PCL is not similar in chemistry, it is a non-piezoelectric polymer and is 
routinely used in tissue engineering. Therefore, by comparing our piezoelectric scaffolds 
to PCL, we were able to evaluate the potential of PVDF-TrFE scaffolds for osteochondral 
tissue engineering applications. Using PCL as a control, our studies indicate that 
piezoelectric scaffolds do enhance MSCs differentiation towards chondrogenesis and 
osteogenesis.  
In the current study, only two donors were compared for biological studies, but in 
future studies, it may be important to investigate multiple donors of MSCs to account for 
donor variability and age group differences for clinical applications. Additionally, higher 
cell seeding density should be investigated to be able to compare to existing strategies in 
cartilage and bone tissue engineering. Though MSCs have limitations, a recent study 
demonstrated MSCs capability to form mechanically functional human cartilage while 
interfaced with demineralized bone scaffold in vitro by mimicking early developmental 
condensation process of MSCs. Engineered tissue resulted in anatomically shaped 
cartilage with physiologically similar zonal distribution of cells [30].  Using similar 
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approach, optimal cell seeding density of MSCs can be determined for achieving tissue 
engineered cartilage on as-spun PVDF-TrFE, which can later be interfaced with tissue 
engineered bone formed on annealed PVDF-TrFE scaffolds to form an engineered 
osteochondral tissue.  
Chondrocytes as a cell source should also be investigated using PVDF-TrFE 
scaffolds for cartilage repair. Chondrocytes have been well established as the preferred 
cell source for cartilage tissue repair since they are primary cartilage cells, which 
generate and maintain cartilage’s extracellular matrix. Multiple studies have 
demonstrated chondrocytes ability to express hyaline cartilage markers, not undergo 
hypertrophy and achieve mechanical properties similar to that of native cartilage using 
scaffold based cartilage tissue engineering [12, 27]. However, chondrocytes have a 
tendency to dedifferentiate and lose its phenotype after passaging through in vitro 
cultures thus forming undesired fibrocartilage.  It will be interesting to see if the inherent 
electrical properties of piezoelectric scaffolds can provide additional cues and retain 
chondrocytes mature phenotype and stimulate functional hyaline cartilage tissue 
regeneration. The findings from these studies will be essential before preclinical studies.  
Additionally, optimizing bioreactor conditions for cell culture media flow rate, 
applied compressive strain and its frequency along with growth factors administration 
will also need to be investigated. The compressive strain and frequency does impact 
MSCs differentiation towards bone or cartilage and influences gene expression profile 
and protein production. In our study, we chose the bioreactor based on well-published 
protocols, however, lowering strain and/or frequency can impact MSCs differentiation 
behavior. Additionally, cartilage tissue engineering studies have suggested that TGF-β3 
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should be discontinued later in culture, which may reduce unwanted molecules 
production such as collagen types I and X in chondrogenesis [31].  Similarly, delayed 
application of compressive strain, for instance, after 14 days of culture, has also shown to 
enhance MSCs chondrogenesis and tissue construct properties [27]. On the other hand, 
bone tissue engineering studies have emphasized the importance of media flow rate that 
can significantly influence cell morphology, proliferation and differentiation. For 
instance, Porter et al. have suggested optimizing flow rate between 0.1 – 0.2 mL/min in 
order to achieve enhanced bone formation in vitro [32]. Therefore, optimizing these 
bioreactor conditions is important and may result in desired hyaline cartilage and bone 
tissues formation in vitro.  
Our study has demonstrated MSCs chondrogenesis on as-spun PVDF-TrFE 
scaffolds and osteogenesis on annealed PVDF-TrFE scaffolds compared to PCL 
scaffolds. Additionally, our studies revealed that annealing enhanced the presence of 
piezoelectric β-phase within scaffolds and had higher voltage output under 
physiologically relevant deformations when compared to as-spun PVDF-TrFE scaffolds. 
PCL scaffolds did not generate electrical output when subjected to similar deformations. 
MSCs differentiation behavior may have been impacted by the differences in voltage 
output from the as-spun and annealed PVDF-TrFE generated during dynamic 
compression, indicating a role of electrical stimulus for MSCs differentiation. There may 
be an optimal electromechanical stimulus needed for achieving native hyaline cartilage 
and bone tissue formation in vitro. Therefore, piezoelectric PVDF-TrFE is an attractive 
polymer due to its inherent electrical properties, which can potentially mimic the native 
bone and cartilage electrical behavior. These studies demonstrated the feasibility of 
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PVDF-TrFE as a scaffold for osteochondral tissue engineering. Further studies should 
focus on understanding the mechanism by which voltage output from the scaffold affects 
MSCs differentiation and ultimately tissue formation.   




CHONDROGENESIS STUDIES RESULTS 
The results shown in this appendix are the actual values from quantitative proteins assay 
and gene expression for MSCs cultured on as-spun PVDF-TrFE, annealed PVDF-TrFE 
and PCL scaffolds, which underwent perfusion and dynamic compression conditions in 
chondrogenic medium in bioreactor system. For statistical analysis, perfusion groups of 
all scaffolds were compared at all time points. Similarly, dynamic scaffolds groups were 
compared at all time points. SPSS 20.0 software (SPSS Inc., IL, USA) was used for 
statistical analysis of all quantitative data. Results are expressed as mean ± standard 
deviation. The results were initially tested for normality (Shapiro Wilk test) and Levene’s 
equal variance test. Two-way Analysis of Variance (ANOVA) and the post hoc multiple 
comparison using Tukey’s tests were applied.  Probability (p) values < 0.05 were 






	   	  
Figure A.1 Cell number on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and 
PCL in chondrogenic cultures, which underwent dynamic compression and perfusion 
only in bioreactor conditions at days 12 and 28. *p<0.05 significant difference between 
day 14 and 28. a p<0.05 significant difference between as-spun PVDF-TrFE and 
annealed PVDF-TrFE in perfusion only at day 14. b p<0.05 significant difference 
between annealed dynamic and other dynamic groups at day 14. c p<0.05 significant 
difference between all dynamic groups at day 28 . d p<0.05 significant difference 
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Figure A.2 Glycosaminoglycans (GAGs) production on scaffolds of as-spun PVDF-
TrFE, annealed PVDF-TrFE and PCL in chondrogenic cultures, which underwent 
dynamic compression and perfusion only in bioreactor conditions at days 12 and 28. 
*p<0.05 significant difference between day 14 and 28. a p<0.05 significant difference 
between as-spun PVDF-TrFE dynamic and other dynamic groups at day 14. b p<0.05 
significant difference between annealed PVDF-TrFE perfusion and other perfusion 
groups at day 14. c p<0.05 significant difference between as-spun perfusion and other 
perfusion groups at day 28. d p<0.05 significant difference between annealed PVDF-
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Figure A.3 Collagen type II production on scaffolds of as-spun PVDF-TrFE, annealed 
PVDF-TrFE and PCL in chondrogenic cultures, which underwent dynamic compression 
and perfusion only in bioreactor conditions at days 12 and 28. *p<0.05 significant 
difference between day 14 and 28. a p<0.05 significant difference between as-spun 
PVDF-TrFE dynamic and other dynamic groups at day 14. b p<0.05 significant 
difference between all perfusion groups at day 14. c p<0.05 significant difference 
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Figure A.4 Collagen type I production on scaffolds of as-spun PVDF-TrFE, annealed 
PVDF-TrFE and PCL in chondrogenic cultures, which underwent dynamic compression 
and perfusion only in bioreactor conditions at days 12 and 28. *p<0.05 significant 
difference between day 14 and 28. a p<0.05 significant difference between PCL dynamic 
and other dynamic groups at day 14. b p<0.05 significant difference between annealed 
PVDF-TrFE and other dynamic groups at day 28. c p<0.05 significant difference between 
all perfusion groups at day 28. d p<0.05 significant difference between as-spun PVDF-
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Figure A.5 Aggrecan gene expression normalized to RPLPO (housekeeping gene) on 
scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in chondrogenic 
cultures, which underwent dynamic compression and perfusion in bioreactor conditions 
at days 12 and 28. *p<0.05 significant difference between day 14 and 28. a p<0.05 
significant difference between PCL dynamic and other dynamic groups at day 14. b 
p<0.05 significant difference between PCL perfusion and annealed PVDF-TrFE 
perfusion at day 14. d p<0.05 significant difference between PCL dynamic and other 
dynamic groups at day 28. c p<0.05 significant difference between PCL perfusion and 
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Figure A.6 SOX9 gene expression normalized to RPLPO (housekeeping gene) on 
scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in chondrogenic 
cultures, which underwent dynamic compression and perfusion in bioreactor conditions 
at days 12 and 28. *p<0.05 significant difference between day 14 and 28. a p<0.05 
significant difference between PCL dynamic and other dynamic groups at day 14. b 
p<0.05 significant difference between as-spun PVDF-TrFE and annealed PVDF-TrFE in 
perfusion condition at day 14. c p<0.05 significant difference between PCL dynamic and 
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Figure A.7 Collagen type II gene expression normalized to RPLPO (housekeeping gene) 
on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in chondrogenic 
cultures, which underwent dynamic compression and perfusion in bioreactor conditions 
at days 12 and 28. *p<0.05 significant difference between day 14 and 28. a p<0.05 
significant difference between as-spun PVDF-TrFE dynamic and other dynamic groups at 
day 14. b p<0.05 significant difference between annealed PVDF-TrFE perfusion and PCL 
perfusion at day 14. c p<0.05 significant difference between annealed PVDF-TrFE 
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Figure A.8 Collagen type IX gene expression normalized to RPLPO (housekeeping 
gene) on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in 
chondrogenic cultures, which underwent dynamic compression and perfusion in 
bioreactor conditions at days 12 and 28. *p<0.05 significant difference between day 14 
and 28. a p<0.05 significant difference between as-spun PVDF-TrFE dynamic and other 
dynamic groups at day 14. b p<0.05 significant difference between annealed PVDF-TrFE 
perfusion and other perfusion groups at day 14. c p<0.05 significant difference between 
as-spun PVDF-TrFE dynamic and other dynamic groups at day 28. d p<0.05 significant 
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Figure A.9 Chondroadherin gene expression normalized to RPLPO (housekeeping gene) 
on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in chondrogenic 
cultures, which underwent dynamic compression and perfusion in bioreactor conditions 
at days 12 and 28. *p<0.05 significant difference between day 14 and 28. a p<0.05 
significant difference between annealed PVDF-TrFE dynamic other dynamic groups at 
day 14. b p<0.05 significant difference between PCL dynamic and annealed PVDF-TrFE 
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Figure A.10 Collagen type X gene expression normalized to RPLPO (housekeeping 
gene) on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in 
chondrogenic cultures, which underwent dynamic compression and perfusion in 
bioreactor conditions at days 12 and 28. *p<0.05 significant difference between day 14 
and 28. a p<0.05 significant difference between as-spun PVDF-TrFE dynamic and other 
dynamic groups at day 14. b p<0.05 significant difference between annealed PVDF-TrFE 
perfusion and other perfusion groups at day 14. c p<0.05 significant difference between 
as-spun PVDF-TrFE dynamic and annealed dynamic at day 28. d p<0.05 significant 
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Figure A.11 Collagen type I gene expression normalized to RPLPO (housekeeping gene) 
on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in chondrogenic 
cultures, which underwent dynamic compression and perfusion in bioreactor conditions 
at days 12 and 28. *p<0.05 significant difference between day 14 and 28. a p<0.05 
significant difference between annealed PVDF-TrFE dynamic and as-spun PVDF-TrFE 
dynamic, at day 28. c p<0.05 significant difference between PCL perfusion and annealed 
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OSTEOGENESIS BIOREACTOR STUDIES RESULTS 
The results shown in this appendix are the actual values from quantitative proteins assay 
and gene expression for MSCs cultured on as-spun PVDF-TrFE, annealed PVDF-TrFE 
and PCL scaffolds, which underwent perfusion and dynamic compression conditions in 
osteogenic medium in bioreactor system. For statistical analysis, perfusion groups of all 
scaffolds were compared at all time points. Similarly, dynamic scaffolds groups were 
compared at all time points. SPSS 20.0 software (SPSS Inc., IL, USA) was used for 
statistical analysis of all quantitative data. Results are expressed as mean ± standard 
deviation. The results were initially tested for normality (Shapiro Wilk test) and Levene’s 
equal variance test. Two-way Analysis of Variance (ANOVA) and the post hoc multiple 
comparison using Tukey’s tests were applied.  Probability (p) values < 0.05 were 






Figure B.1 Cell number on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and 
PCL in osteogenic cultures, which underwent dynamic compression and perfusion only in 
bioreactor conditions at days 14 and 28. a p<0.05 significant difference between annealed 
PVDF-TrFE and other groups in dynamic at day 14. b p<0.05 significant difference 
between as-spun PVDF-TrFE and other perfusion groups at day 28. c p<0.05 significant 
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Figure B.2 Alkaline phosphatase activity on scaffolds of as-spun PVDF-TrFE, annealed 
PVDF-TrFE and PCL in osteogenic cultures, which underwent dynamic compression and 
perfusion only in bioreactor conditions at days 14 and 28. a p<0.05 significant difference 
between PCL and other groups in dynamic at day 14. b p<0.05 significant difference 
between PCL perfusion and other perfusion groups at day 14. c p<0.05 significant 
difference between PCL dynamic and other dynamic groups at day 28. d p<0.05 
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Figure B.3 Mineralization on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE 
and PCL in osteogenic cultures, which underwent dynamic compression and perfusion 
only in bioreactor conditions at days 14 and 28. *p<0.05 significant difference between 
day 14 and 28. a p<0.05 significant difference between annealed PVDF-TrFE and other 
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Figure B.4 Osteocalcin production on scaffolds of as-spun PVDF-TrFE, annealed PVDF-
TrFE and PCL in osteogenic cultures, which underwent dynamic compression and 
perfusion only in bioreactor conditions at days 14 and 28. *p<0.05 significant difference 













Dynamic  Perfusion Dynamic  Perfusion Dynamic  Perfusion 
















Figure B.5 RUNX2 gene expression normalized to RPLPO (housekeeping) on scaffolds 
of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in osteogenic cultures, which 
underwent dynamic compression and perfusion only in bioreactor conditions at days 14 
and 28. *p<0.05 significant difference between day 14 and 28. a p<0.05 significant 
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Figure B.6 Alkaline phosphatase gene expression normalized to RPLPO (housekeeping) 
on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in osteogenic 
cultures, which underwent dynamic compression and perfusion only in bioreactor 
conditions at days 14 and 28. a p<0.05 significant difference between PCL and other 
groups in dynamic at day 14. b p<0.05 significant difference between PCL perfusion and 
other perfusion groups at day 14. c p<0.05 significant difference between annealed 
PVDF-TrFE dynamic and other dynamic groups at day 28. d p<0.05 significant 
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Figure B.7 Collagen type I gene expression normalized to RPLPO (housekeeping) on 
scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in osteogenic cultures, 
which underwent dynamic compression and perfusion only in bioreactor conditions at 
days 14 and 28. a p<0.05 significant difference between PCL perfusion and other groups 
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Figure B.8 Osteopontin gene expression normalized to RPLPO (housekeeping) on 
scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in osteogenic cultures, 
which underwent dynamic compression and perfusion only in bioreactor conditions at 
days 14 and 28. a p<0.05 significant difference between annealed PVDF-TrFE dynamic 
and other groups in dynamic at day 14. b p<0.05 significant difference between annealed 
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Figure B.9 Osteocalcin gene expression normalized to RPLPO (housekeeping) 
production on scaffolds of as-spun PVDF-TrFE, annealed PVDF-TrFE and PCL in 
osteogenic cultures, which underwent dynamic compression and perfusion only in 
bioreactor conditions at days 14 and 28. *p<0.05 significant difference between day 14 
and 28. a p<0.05 significant difference between annealed PVDF-TrFE dynamic and other 
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